Carlyle Group Inc.
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to the Condensed Consolidated Financial Statements
- Organization
The Carlyle Group Inc., together with its consolidated subsidiaries (“Carlyle” or the “Company”), is one of the
world’s largest global investment firms that deploys private capital across its business and conducts its operations
through three reportable segments: Global Private Equity, Global Credit, and Carlyle AlpInvest (see Note 14,
Segment Reporting). Carlyle typically serves as the general partner, investment manager, or collateral manager,
making day-to-day investment decisions concerning the assets of the products within these segments.
The Carlyle Group Inc. was formed in Delaware as a partnership on July 18, 2011. On January 1, 2020, the
Company completed its conversion from a Delaware limited partnership named The Carlyle Group L.P. into a
Delaware Corporation named The Carlyle Group Inc. (the conversion, together with such restructuring steps and
related transactions, the “Conversion”).
- Summary of Significant Accounting Policies
Basis of Presentation
The accompanying condensed consolidated financial statements are prepared in accordance with accounting
principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of the Company and its
consolidated subsidiaries. In addition, certain Carlyle-affiliated funds, related co-investment entities, and certain
CLOs managed by the Company (collectively, the “Consolidated Funds”) have been consolidated in the
accompanying financial statements. Generally, the consolidation of the Consolidated Funds has a gross-up effect on
assets, liabilities and cash flows, but has no net effect on the net income attributable to the Company beyond the
capital contributed by the Company to the Consolidated Funds. The economic ownership interests of the other
investors in the Consolidated Funds are reflected as non-controlling interests in consolidated entities in the
accompanying condensed consolidated financial statements. All of the investments held by the Consolidated Funds
and notes issued by the consolidated CLOs are presented at their estimated fair values in the Company’s
condensed consolidated balance sheets. Interest and other income of the Consolidated Funds, interest expense
and other expenses of the Consolidated Funds, and net investment income (losses) of Consolidated Funds are
included in the Company’s condensed consolidated statements of operations.
Management has determined that the Company’s funds are investment companies under U.S. GAAP for the
purposes of financial reporting. U.S. GAAP for an investment company requires investments to be recorded at
estimated fair value and the unrealized gains and/or losses in an investment’s fair value are recognized on a current
basis in the statements of operations. Additionally, the funds do not consolidate their majority-owned and controlled
investments. In the preparation of these condensed consolidated financial statements, the Company has retained
the specialized accounting for the funds.
The accompanying condensed consolidated financial statements have been prepared in accordance with U.S.
GAAP for interim financial information. These statements, including notes, have not been audited, exclude some of
the disclosures required for annual financial statements, and should be read in conjunction with the audited
consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended
December 31, 2025 filed with the U.S. Securities and Exchange Commission (“SEC”) on February 27, 2026. The
operating results presented for interim periods are not necessarily indicative of the results that may be expected for
any other interim period or for the entire year. In the opinion of management, the condensed consolidated financial
statements reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair
presentation of the financial condition and results of operations for the interim periods presented.
Principles of Consolidation
The Company consolidates all entities that it controls either through a majority voting interest or as the primary
beneficiary of variable interest entities (“VIEs”).
The Company evaluates (1) whether it holds a variable interest in an entity, (2) whether the entity is a VIE, and
(3) whether the Company’s involvement would make it the primary beneficiary. In evaluating whether the Company
holds a variable interest, fees (including management fees, incentive fees and performance allocations) that are
customary and commensurate with the level of services provided, and where the Company does not hold other
economic interests in the entity that would absorb more than an insignificant amount of the expected losses or
returns of the entity, are not considered variable interests. The Company considers all economic interests, including
indirect interests, to determine if a fee is considered a variable interest.
For those entities where the Company holds a variable interest, the Company determines whether each of
these entities qualifies as a VIE and, if so, whether or not the Company is the primary beneficiary. The assessment
of whether the entity is a VIE is generally performed qualitatively, which requires judgment. These judgments
include: (a) determining whether the equity investment at risk is sufficient to permit the entity to finance its activities
without additional subordinated financial support, (b) evaluating whether the equity holders, as a group, can make
decisions that have a significant effect on the economic performance of the entity, (c) determining whether two or
more parties’ equity interests should be aggregated, and (d) determining whether the equity investors have
proportionate voting rights to their obligations to absorb losses or rights to receive returns from an entity.
For entities that are determined to be VIEs, the Company consolidates those entities where it has concluded it
is the primary beneficiary. The primary beneficiary is defined as the variable interest holder with (a) the power to
direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) the obligation
to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the
VIE. In evaluating whether the Company is the primary beneficiary, the Company evaluates its economic interests in
the entity held either directly or indirectly by the Company.
As of September 30, 2026, assets and liabilities of the consolidated VIEs reflected in the condensed
consolidated balance sheets were$15.0 billion and$12.4 billion, respectively. As of December 31, 2025, assets and
liabilities of the consolidated VIEs reflected in the consolidated balance sheets were$14.0 billion and$11.7 billion,
respectively. Except to the extent of the consolidated assets of the VIEs, the holders of the consolidated VIEs’
liabilities generally do not have recourse to the Company.
The Company’s Consolidated Funds are primarily CLOs, which are VIEs that issue loans payable that are
backed by diversified collateral asset portfolios consisting primarily of loans or structured debt. In exchange for
managing the collateral for the CLOs, the Company earns investment management fees, including in some cases
subordinated management fees and contingent incentive fees. In cases where the Company consolidates the CLOs
(primarily because of a retained interest that is significant to the CLO), those management fees and contingent
incentive fees have been eliminated as intercompany transactions. As of September 30, 2026, the Company held
$534.3 million of investments in these CLOs which represents its maximum risk of loss. The Company’s
investments in these CLOs are generally subordinated to other interests in the entities and entitle the Company to
receive a pro rata portion of the residual cash flows, if any, from the entities. Investors in the CLOs have no
recourse against the Company for any losses sustained in the CLO structure. The Company’s Consolidated Funds
also include certain investment funds in the Global Private Equity segment that are accounted for as consolidated
VIEs due to the Company providing financing to bridge investment purchases. As of September 30, 2026, the
Company held$980.0 million of notes receivable and investments related to these investment funds which
represents its maximum risk of loss. The Company’s Consolidated Funds also include certain funds in the Global
Credit and Carlyle AlpInvest segments that are accounted for as consolidated VIEs due to the Company having
either a significant direct interest in these funds or significant indirect interest via the Company’s investment in
Fortitude (see Note 4, Investments).
Entities that do not qualify as VIEs are generally assessed for consolidation as voting interest entities. Under
the voting interest entity model, the Company consolidates those entities it controls through a majority voting
interest.
All significant inter-entity transactions and balances of entities consolidated have been eliminated.
Investments in Unconsolidated Variable Interest Entities
The Company holds variable interests in certain VIEs that are not consolidated because the Company is not
the primary beneficiary, including its investments in certain credit vehicles and certain Carlyle AlpInvest vehicles, as
well as its strategic investment in NGP Management Company, L.L.C. (“NGP Management” and, together with its
affiliates, “NGP”). Refer to Note 4, Investments, for information on the strategic investment in NGP. The Company’s
involvement with such entities is in the form of direct or indirect equity interests and fee arrangements. The
maximum exposure to loss represents the loss of assets recognized by the Company relating to its variable
interests in these unconsolidated entities.
The assets recognized in the Company’s condensed consolidated balance sheets related to the Company’s
variable interests in these non-consolidated VIEs were as follows:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Investments | $668.9 | $776.5 |
| Accrued performance allocations | 832.6 | 756.0 |
| Management fee receivables | 49.8 | 57.2 |
| Total | $1,551.3 | $1,589.7 |
These amounts represent the Company’s maximum exposure to loss related to the unconsolidated VIEs as of
September 30, 2026 and December 31, 2025.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make
assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of
revenues and expenses during the reporting period. Management’s estimates are based on historical experiences
and other factors, including expectations of future events that management believes to be reasonable under the
circumstances. It also requires management to exercise judgment in the process of applying the Company’s
accounting policies. Assumptions and estimates regarding the valuation of investments and their resulting impact on
performance allocations and incentive fees involve a higher degree of judgment and complexity and these
assumptions and estimates may be significant to the condensed consolidated financial statements and the resulting
impact on performance allocations and incentive fees. Actual results could differ from these estimates and such
differences could be material.
Revenue Recognition
The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606,
Revenue from Contracts with Customers. Revenue is recognized when the Company transfers promised goods or
services to customers in an amount that reflects the consideration to which the Company expects to be entitled in
exchange for those goods or services. ASC 606 includes a five-step framework that requires an entity to: (i) identify
the contract(s) with a customer, which includes assessing the collectability of the consideration to which it will be
entitled in exchange for the goods or services transferred to the customer, (ii) identify the performance obligations in
the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in
the contract, and (v) recognize revenue when the entity satisfies a performance obligation.
The Company accounts for performance allocations that represent a performance-based capital allocation
from fund limited partners to the Company (commonly known as “carried interest”) as earnings from financial assets
within the scope of ASC 323, Investments—Equity Method and Joint Ventures, and therefore are not in the scope of
ASC 606. In accordance with ASC 323, the Company records equity method income (losses) as a component of
investment income based on the change in its proportionate claim on net assets of the investment fund, including
performance allocations, assuming the investment fund was liquidated as of each reporting date pursuant to each
fund’s governing agreements. See Note 4, Investments, for additional information on the components of
investments and investment income. Performance fees that do not meet the definition of performance-based capital
allocations are in the scope of ASC 606 and are included in incentive fees in the condensed consolidated
statements of operations. The calculation of unrealized performance revenues utilizes investment valuations of the
funds’ underlying investments, which are derived using the policies, methodologies and templates prepared by the
Company’s valuation group, as described in Note 3, Fair Value Measurement.
While the determination of who is the customer in a contractual arrangement will be made on a contract-by-
contract basis, the customer will generally be the investment fund for the Company’s significant management and
advisory contracts. The customer determination impacts the Company’s analysis of the accounting for contract
costs.
Fund Management Fees
The Company provides management services to funds in which it holds a general partner interest or to funds
or certain portfolio companies with which it has an investment advisory or investment management agreement. The
Company considers the performance obligations in its contracts with its funds to be the promise to provide (or to
arrange for third parties to provide) investment management services related to the management, policies and
operations of the funds.
As it relates to the Company’s performance obligation to provide investment management services, the
Company typically satisfies this performance obligation over time as the services are rendered, as the funds
simultaneously receive and consume the benefits provided as the Company performs the service. The transaction
price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the
promised services to the funds. Management fees earned from each investment management contract over the
contract life represent variable consideration because the consideration the Company is entitled to varies based on
fluctuations in the basis for the management fee, for example fund net asset value (“NAV”) or assets under
management (“AUM”). Given that the management fee basis is susceptible to market factors outside of the
Company’s influence, management fees are constrained and, therefore, estimates of future period management
fees are generally not included in the transaction price. Revenue recognized for the investment management
services provided is generally the amount determined at the end of the period because that is when the uncertainty
for that period is resolved.
Management fees may be charged in advance or arrears, and at a monthly, quarterly, or semi-annual cadence
pursuant to the terms of the investment management agreement. The range of management fee rates and the base
on which they are earned vary based on the product’s strategy, expected term, and other factors, but generally
encompass the following:
For closed-end carry funds in the Global Private Equity and Global Credit segments:
During the fund’s commitment period, generally 1.0% to 2.0% of limited partners’ capital
commitments in the case of Global Private Equity and invested capital in the case of Global
Credit, and
Following the expiration or termination of the investment period, generally 0.5% to 2.0% of the
lower of cost or fair value of invested capital.
For carry funds and other fund vehicles in the Carlyle AlpInvest segment:
During the fund’s commitment period, generally 0.25% to 1.5% of the vehicle’s capital
commitments, and
Following the expiration of the commitment fee period, generally 0.25% to 1.5% on (i) the net
invested capital, (ii) the lower of cost or net asset value of the capital invested, or (iii) the net
asset value for unrealized investments.
For CLOs and other structured products in the Global Credit segment,0.4% to 0.5% based on the total
par amount of assets or the aggregate principal amount of the notes in the CLO.
For certain of the Company’s perpetual capital strategies and separately managed accounts in the Global
Credit segment,0.10% to 0.75% based on invested capital or the fair value of the underlying assets.
For certain cross platform products as well as the Company’s business development companies in the
Global Credit segment,1.0% to 1.5% of gross assets, excluding cash and cash equivalents, or net asset
value.
For the Company’s retail-oriented perpetual capital products, including CTAC, ETAC, CPEP, CAPM, and
CAPS funds, generally 1.0% to 1.25% of net asset value.
The Company also provides transaction advisory and portfolio advisory services to the portfolio companies,
and where covered by separate contractual agreements, recognizes fees for these services when the performance
obligation has been satisfied and collection is reasonably assured. The Company is generally required to offset its
fund management fees earned from the funds that have invested in the portfolio companies to which the service has
been provided by a percentage of the transaction and advisory fees allocable to those funds. This amount is
referred to as the “rebate offset,” and is generally 100%. Transaction and advisory fees allocable to funds that do
not pay fund management fees do not have a rebate offset. The Company also recognizes underwriting fees from
the Company’s loan syndication and capital markets business, Carlyle Global Capital Markets. Fund management
fees include transaction and portfolio advisory fees, as well as capital markets fees, of$27.7 million and$21.1
million for thethree months ended September 30, 2026 and 2025, respectively, and$185.5 million and$143.6
million for thenine months ended September 30, 2026 and 2025, respectively, net of rebate offsets as defined in the
respective fund limited partnership agreements.
Fund management fees exclude the reimbursement of any partnership expenses paid by the Company on
behalf of the Carlyle funds pursuant to the limited partnership agreements, including amounts related to the pursuit
of actual, proposed, or unconsummated investments, professional fees, expenses associated with the acquisition,
holding and disposition of investments, and other fund administrative expenses. For the professional fees that the
Company arranges for the investment funds, the Company concluded that the nature of its promise is to arrange for
the services to be provided and it does not control the services provided by third parties before they are transferred
to the customer. Therefore, the Company concluded it is acting in the capacity of an agent. Accordingly, the
reimbursement for these professional fees paid on behalf of the investment funds is presented on a net basis in
general, administrative and other expenses in the condensed consolidated statements of operations.
The Company also incurs certain costs, primarily employee travel and entertainment costs, employee
compensation and systems costs, for which it receives reimbursement from the investment funds in connection with
its performance obligation to provide investment and management services. For reimbursable travel, compensation
and systems costs, the Company concluded it controls the services provided by its employees and the resources
used to develop applicable systems before they are transferred to the customer and therefore is a principal.
Accordingly, the reimbursement for these costs incurred by the Company to manage the fund limited partnerships
are presented on a gross basis in interest and other income in the condensed consolidated statements of
operations and the expense in general, administrative and other expenses or cash-based compensation and
benefits expenses in the condensed consolidated statements of operations.
Incentive Fees
The Company is also entitled to receive performance-based incentive fees when the return on assets under
management exceeds certain benchmark returns or other performance targets. In such arrangements, the
Company is entitled to an incentive fee generally between 10.0% and 17.5% of either pre-incentive investment
income or net profits, in most instances subject to a quarterly hurdle rate and catch-up, payable quarterly. Incentive
fees are recognized when the performance benchmark has been achieved. Incentive fees are variable
consideration because they are contingent upon the investment vehicle achieving stipulated investment return
hurdles. Investment returns are highly susceptible to market factors outside of the Company’s influence.
Accordingly, incentive fees are constrained until all uncertainty is resolved. Estimates of future period incentive fees
are generally not included in the transaction price because these estimates are constrained. The transaction price
for incentive fees is generally the amount determined at the end of each accounting period to which they relate
because that is when the uncertainty for that period is resolved, as these fees are not subject to clawback.
Investment Income (Loss), including Performance Allocations
Investment income (loss) represents the unrealized and realized gains and losses resulting from the
Company’s equity method investments, including any associated general partner performance allocations, and
other principal investments, including CLOs.
General partner performance allocations consist of the allocation of profits from certain of the funds to which
the Company is entitled (commonly known as carried interest).
For closed-end carry funds in the Global Private Equity and Global Credit segments, the Company is generally
entitled to a 20% allocation (or approximately 2% to 12.5% for most of the Carlyle AlpInvest segment carry fund
vehicles) of the net realized income or gain as a carried interest after returning the invested capital, the allocation of
preferred returns of generally 7% to 9% and return of certain fund costs (generally subject to catch-up provisions as
set forth in the fund limited partnership agreement). These terms may vary on longer-dated funds, certain credit
funds, and external co-investment vehicles. Carried interest is recognized upon appreciation of the funds’
investment values above certain return hurdles set forth in each respective partnership agreement. The Company
recognizes revenues attributable to performance allocations based upon the amount that would be due pursuant to
the fund partnership agreement at each period end as if the funds were terminated at that date. Accordingly, the
amount recognized as investment income for performance allocations reflects the Company’s share of the gains
and losses of the associated funds’ underlying investments measured at their then-current fair values relative to the
fair values as of the end of the prior period. Because of the inherent uncertainty, these estimated values may differ
significantly from the values that would have been used had a ready market for the investments existed, and it is
reasonably possible that the difference could be material.
Carried interest is ultimately realized when: (i) an underlying investment is profitably disposed of, (ii) certain
costs borne by the limited partner investors have been reimbursed, (iii) the fund’s cumulative returns are in excess
of the preferred return, and (iv) the Company has decided to collect carry rather than return additional capital to
limited partner investors. Realized carried interest may be required to be returned by the Company in future periods
if the fund’s investment values decline below certain levels. When the fair value of a fund’s investments remains
constant or falls below certain return hurdles, previously recognized performance allocations are reversed. In all
cases, each fund is considered separately in this regard, and for a given fund, performance allocations can never be
negative over the life of a fund. If upon a hypothetical liquidation of a fund’s investments at their then-current fair
values, previously recognized and distributed carried interest would be required to be returned, a liability is
established for the potential giveback obligation. See Note 7, Commitments and Contingencies, for additional
information on the Company’s giveback obligations.
Principal investment income (loss) is realized when the Company redeems all or a portion of its investment or
when the Company receives or is due cash income, such as dividends or distributions. Unrealized principal
investment income (loss) results from the Company’s proportionate share of the investee’s unrealized earnings,
including changes in the fair value of the underlying investment, as well as the reversal of unrealized gain (loss) at
the time an investment is realized. As it relates to the Company’s investments in NGP (see Note 4, Investments),
principal investment income includes the related amortization of the basis difference between the Company’s
carrying value of its investment and the Company’s share of underlying net assets of the investee, as well as the
compensation expense associated with compensatory arrangements provided by the Company to employees of its
equity method investee, and impairment charges.
Interest Income
Interest income is recognized when earned. For debt securities representing non-investment grade beneficial
interests in securitizations, the effective yield is determined based on the estimated cash flows of the security.
Changes in the effective yield of these securities due to changes in estimated cash flows are recognized on a
prospective basis as adjustments to interest income in future periods. Interest income earned by the Company is
included in interest and other income in the accompanying condensed consolidated statements of operations.
Interest income of the Consolidated Funds is included in interest and other income of Consolidated Funds in the
accompanying condensed consolidated statements of operations. See Note 4, Investments, for additional
information on investments of Consolidated Funds.
Credit Losses
The Company measures all expected credit losses for financial assets held at the reporting date in
accordance with ASC 326, Financial Instruments—Credit Losses, based on historical experience, current
conditions, and reasonable and supportable forecasts. The Company assesses the collection risk characteristics of
the outstanding amounts in its due from affiliates balance into the following pools of receivables:
Reimbursable fund expenses receivables,
Management fee receivables,
Incentive fee receivables,
Transaction fee receivables,
Portfolio fee receivables, and
Notes receivable.
The Company generally utilizes either historical credit loss information or discounted cash flows to calculate
expected credit losses for each pool. The Company’s receivables are predominantly with its investment funds,
which have low risk of credit loss based on the Company’s historical experience. Historical credit loss data may be
adjusted for current conditions and reasonable and supportable forecasts, including the Company’s expectation of
near-term realization based on the liquidity of the affiliated investment funds.
Compensation and Benefits
Cash-Based Compensation and Benefits – Cash-based compensation and benefits includes salaries, bonuses
(discretionary awards and guaranteed amounts), performance payment arrangements, and benefits paid and
payable to Carlyle employees. Bonuses are accrued over the service period to which they relate.
Equity-Based Compensation – Compensation expense relating to the issuance of equity-based awards is
measured at fair value on the grant date. The compensation expense for awards that vest over a future service
period is recognized over the relevant service period on a straight-line basis. The compensation expense for awards
that do not require future service is recognized immediately. Cash settled equity-based awards are classified as
liabilities and are re-measured at the end of each reporting period. The compensation expense for awards that
contain performance conditions is recognized when it is probable that the performance conditions will be achieved.
The compensation expense for awards that contain market conditions is based on a grant-date fair value that
factors in the probability that the market conditions will be achieved and is recognized over the requisite service
period on a straight-line basis.
Certain equity-based awards contain dividend-equivalent rights, which are subject to the same terms and
conditions, including with respect to vesting and settlement, that apply to the related award. Dividend-equivalents
are accounted for as a reclassification from retained earnings to additional paid-in capital at the time dividends are
declared and do not result in incremental compensation expense.
Equity-based awards issued to non-employees are generally recognized as general, administrative and other
expenses, except to the extent they are recognized as part of the Company’s equity method earnings because they
are issued to employees of equity method investees.
The Company recognizes equity-based award forfeitures in the period they occur as a reversal of previously
recognized compensation expense for awards that vest based on service and/or performance conditions. The
reduction in compensation expense is determined based on the specific awards forfeited during that period.
Furthermore, the Company recognizes all excess tax benefits and deficiencies as income tax benefit or expense in
the condensed consolidated statements of operations. For awards with a market condition (e.g., achievement of
certain stock price hurdles) that are forfeited due to the market condition not being achieved, the related equity-
based compensation expense is not reversed.
Performance Allocations and Incentive Fee Related Compensation – A portion of the performance allocations
and incentive fees and certain other interests earned is due to employees and advisors of the Company. These
amounts are accounted for as profit sharing interests in compensation expense in a systematic and rational manner
in conjunction with the recognition of the related performance allocations and incentive fee revenue and, until paid,
are recognized as a component of the accrued compensation and benefits liability. The liability is measured
assuming the hypothetical liquidation of the associated funds’ underlying investments as of the measurement date.
Accordingly, upon a reversal of performance allocations or incentive fee revenue, the related compensation
expense, if any, is also reversed. As any vesting requirement is accelerated upon realization, the service period is
not considered substantive when recording the liability based on the hypothetical liquidation value. As of
September 30, 2026 and December 31, 2025, the Company recorded a liability of$4.0 billion and$5.1 billion,
respectively, related to the portion of accrued performance allocations and incentive fees due to employees and
advisors, which was included in accrued compensation and benefits in the accompanying condensed consolidated
balance sheets.
Income Taxes
The Company is a corporation for U.S. federal income tax purposes and is subject to U.S. federal, state, local,
and foreign income taxes. The Company is subject to periodic audit by U.S. federal, state, local, and foreign taxing
authorities. The interim provision for income taxes is generally calculated using an estimated annual effective tax
rate applied to year-to-date ordinary income in accordance with ASC 740, Income Taxes.
Non-controlling Interests
Non-controlling interests in consolidated entities represent the component of equity in consolidated entities
held by third-party investors. These interests are adjusted for general partner allocations which occur during the
reporting period. Any change in ownership of a subsidiary while the controlling financial interest is retained is
accounted for as an equity transaction between the controlling and non-controlling interests. Transaction costs
incurred in connection with such changes in ownership of a subsidiary are recorded as a direct charge to equity.
Earnings Per Common Share
The Company computes earnings per common share in accordance with ASC 260, Earnings Per Share. Basic
earnings per common share is calculated by dividing net income (loss) attributable to the common shares of the
Company by the weighted-average number of common shares outstanding for the period. Diluted earnings per
common share reflects the assumed conversion of all dilutive securities. The Company applies the treasury stock
method to determine the dilutive weighted-average common shares outstanding for certain equity-based
compensation awards. For certain equity-based compensation awards that contain performance or market
conditions, the number of contingently issuable common shares is included in diluted earnings per common share
based on the number of common shares, if any, that would be issuable under the terms of the awards if the end of
the reporting period were the end of the contingency period, if the result is dilutive.
Fair Value of Financial Instruments
The underlying entities that the Company manages and invests in (and in certain cases, consolidates) are
primarily investment companies which account for their investments at estimated fair value.
The fair value measurement accounting guidance under ASC 820, Fair Value Measurement, establishes a
hierarchical disclosure framework which ranks the observability of market price inputs used in measuring financial
instruments at fair value. The observability of inputs is impacted by a number of factors, including the type of
financial instrument, the characteristics specific to the financial instrument and the state of the marketplace,
including the existence and transparency of transactions between market participants. Financial instruments with
readily available quoted prices, or for which fair value can be measured from quoted prices in active markets, will
generally have a higher degree of market price observability and a lesser degree of judgment applied in determining
fair value.
Financial instruments measured and reported at fair value are classified and disclosed based on the
observability of inputs used in the determination of fair values, as follows:
Level I– inputs to the valuation methodology are quoted prices available in active markets for identical
instruments as of the reporting date. The type of financial instruments in this category include
unrestricted securities, such as equities and derivatives, listed in active markets. The Company does
not adjust the quoted price for these instruments, even in situations where the Company holds a large
position and a sale could reasonably impact the quoted price.
Level II – inputs to the valuation methodology are other than quoted prices in active markets, which are
either directly or indirectly observable as of the reporting date. The types of financial instruments in this
category include less liquid and restricted securities listed in active markets, securities traded in other
than active markets, government and agency securities, and certain over-the-counter derivatives where
the fair value is based on observable inputs.
Level III – inputs to the valuation methodology are unobservable and significant to overall fair value
measurement. The inputs into the determination of fair value require significant management judgment
or estimation. The types of financial instruments in this category include investments in privately-held
entities, non-investment grade residual interests in securitizations, collateralized loan obligations, and
certain over-the-counter derivatives where the fair value is based on unobservable inputs.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy.
In such cases, the determination of which category within the fair value hierarchy is appropriate for any given
financial instrument is based on the lowest level of input that is significant to the fair value measurement. The
Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires
judgment and considers factors specific to the financial instrument.
In certain cases, debt and equity securities (including corporate treasury investments) are valued on the basis
of prices from an orderly transaction between market participants provided by reputable dealers or pricing services.
In determining the value of a particular investment, pricing services may use certain information with respect to
transactions in such investments, quotations from dealers, pricing matrices, market transactions in comparable
investments, and various relationships between investments.
In the absence of observable market prices, the Company values its investments and its funds’ investments
using valuation methodologies applied on a consistent basis. For some investments little market activity may exist.
Management’s determination of fair value is then based on the best information available in the circumstances and
may incorporate management’s own assumptions and involve a significant degree of judgment, taking into
consideration a combination of internal and external factors, including the appropriate risk adjustments for non-
performance and liquidity risks. Investments for which market prices are not observable include private investments
in the equity and debt of operating companies and real assets, CLO investments and CLO loans payable, and fund
investments. The valuation technique for each of these investmentsis described below:
Investments in Operating Companies and Real Assets – The fair values of private investments in operating
companies and real assets are generally determined by reference to the income approach (including the
discounted cash flow method and the income capitalization method) and the market approach (including the
comparable publicly traded company method and the comparable transaction method). Valuations under
these approaches are typically derived by reference to investment-specific inputs (such as projected cash
flows, earnings before interest, taxes, depreciation and amortization (“EBITDA”), and net operating income)
combined with market-based inputs (such as discount rates, EBITDA multiples and capitalization rates). In
many cases, the investment-specific inputs are unaudited at the time received. Management may also
adjust the market-based inputs to account for differences between the subject investment and the
companies, assets or investments used to derive the market-based inputs. Adjustments to observable
valuation measures are frequently made upon the initial investment to calibrate the initial investment
valuation to industry observable inputs. Such adjustments are made to align the investment to observable
industry inputs for differences in size, profitability, projected growth rates, geography, capital structure, and
other factors as applicable. The adjustments are then reviewed with each subsequent valuation to assess
how the investment has evolved relative to the observable inputs. Additionally, the investment may be
subject to certain specific risks and/or development milestones which are also taken into account in the
valuation assessment. Option pricing models and similar tools may also be considered but do not currently
drive a significant portion of operating company or real asset valuations and are used primarily to value
warrants, derivatives, certain restrictions, and other atypical investment instruments.
Credit-Oriented Investments –Where available, the fair values of credit-oriented investments (including
corporate treasury investments) are generally determined on the basis of prices between market
participants provided by reputable dealers or pricing services. In determining the value of a particular
investment, pricing services may use certain information with respect to transactions in such investments,
quotations from dealers, pricing matrices, market transactions in comparable investments, and various
relationships between investments. Specifically, for investments in distressed debt and corporate loans and
bonds, the fair values are generally determined by valuations of comparable investments. Where such
pricing is not available or reliable, the Company may utilize other valuation techniques, including the
discounted cash flow method.
CLO Investments and CLO Loans Payable – The Company measures the financial liabilities of its
consolidated CLOs based on the fair value of the financial assets of its consolidated CLOs, as the Company
believes the fair value of the financial assets are more observable. The fair values of the CLO loan and
bond assets are primarily based on quotations from reputable dealers or relevant pricing services. In
situations where valuation quotations are unavailable, the assets are valued based on similar securities,
market index changes, and other factors. The Company performs certain procedures to ensure the reliability
of the quotations from pricing services for its CLO assets and CLO structured asset positions, which
generally includes corroborating prices with a discounted cash flow analysis. Generally, the loan and bond
assets of the CLOs are not publicly traded and are classified as Level III. The fair values of the CLO
structured asset positions are determined based on both discounted cash flow analyses and third-party
quotes. Those analyses consider the position size, liquidity, current financial condition of the CLOs, the
third-party financing environment, reinvestment rates, recovery lags, discount rates, and default forecasts
and are compared to broker quotations from market makers and third-party dealers.
The Company measures the CLO loan payables held by third-party beneficial interest holders on the basis
of the fair value of the financial assets of the CLO and the beneficial interests held by the Company. The
Company continues to measure the CLO loans payable that it holds at fair value based on relevant pricing
services or discounted cash flow analyses, as described above.
Fund Investments– The Company’s primary and secondary investments in external funds are generally
valued as its proportionate share of the most recent net asset value provided by the third-party general
partners of the underlying fund partnerships, adjusted for subsequent cash flows received from or
distributed to the underlying fund partnerships. The Company also adjusts for any changes in the market
prices of public securities held by the underlying fund partnerships and may also apply a market adjustment
to reflect the estimated change in the fair value of the underlying fund partnerships’ non-public investments
from the date of the most recent net asset value provided by the third-party general partners.
Investment professionals with responsibility for the underlying investments are responsible for preparing the
investment valuations pursuant to the policies, methodologies, and templates prepared by the Company’s valuation
group, which is a team made up of dedicated valuation professionals reporting to the Company’s Chief Accounting
Officer. The valuation group is responsible for maintaining the Company’s valuation policy and related guidance,
templates, and systems that are designed to be consistent with the guidance found in ASC 820. These valuations,
inputs, and preliminary conclusions are reviewed by the fund management teams. The valuations are then reviewed
and approved by the respective fund valuation subcommittees, which include the respective fund head(s), segment
head, Chief Financial Officer, and Chief Accounting Officer, as well as members of the valuation group. The
valuation group compiles the aggregate results and significant matters and presents them for review and approval
by the global valuation committee, which includes, among others, the Company’s Chief Financial Officer, Chief
Accounting Officer, and the business segment heads, and is observed by the Chief Compliance Officer, the Chief
Audit Executive, the Chief Risk Officer, the Company’s Audit Committee, and others. Additionally, each quarter a
sample of valuations are reviewed by external valuation firms. Valuations of the funds’ investments are used in the
calculation of accrued performance allocations.
Investments, at Fair Value
Investments include (i) the Company’s ownership interests (typically general partner interests) in the Funds,
including the Company’s investment in Fortitude held through Carlyle FRL (which are accounted for as equity
method investments), (ii) the Company’s investment in NGP (which is accounted for as an equity method
investment), (iii) the investments held by the Consolidated Funds (which are presented at fair value in the
Company’s condensed consolidated financial statements), and (iv) certain credit-oriented investments, including
investments in the CLOs and the common shares of Carlyle Secured Lending, Inc. (“CGBD,” see Note 4,
Investments, to this Quarterly Report on Form 10-Q and Note 9, Related Party Transactions, to our Annual Report
on Form 10-K for the year ended December 31, 2025 for more information), which are accounted for as trading
securities.
Upon the sale of a security or other investment, the realized net gain or loss is computed on a weighted
average cost basis, with the exception of the investments held by the CLOs, which compute the realized net gain or
loss on a first in, first out basis. Securities transactions are recorded on a trade date basis.
Equity Method Investments
The Company accounts for all investments in which it has or is otherwise presumed to have significant
influence, including investments in unconsolidated investment funds and the Company’s investment in NGP, using
the equity method of accounting. The carrying value of equity method investments is determined based on amounts
invested by the Company, adjusted for the equity in earnings or losses of the investee (including performance
allocations) allocated based on the respective partnership agreement, less distributions received. The Company
evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that
the carrying amounts of such investments may not be recoverable.
Cash and Cash Equivalents
Cash and cash equivalents include cash held at banks and cash held for distributions, including investments
with original maturities of less than three months when purchased. The Company is subject to credit risk should a
financial institution be unable to fulfill its obligations and if balances held at a financial institution exceed insured
limits.
Cash and Cash Equivalents Held at Consolidated Funds
Cash and cash equivalents held at Consolidated Funds consists of cash and cash equivalents held by the
Consolidated Funds, which, although not legally restricted, is not available to fund the general liquidity needs of the
Company.
Restricted Cash
Restricted cash primarily represents cash that is subject to legal, regulatory, or contractual restrictions on its
withdrawal or use for general operating purposes, as well as certain amounts held on behalf of Carlyle funds. As of
September 30, 2026 and December 31, 2025, the Company held restricted cash of$0.8 million and$3.4 million,
respectively, which are included in Deposits and other in the condensed consolidated balance sheets.
Corporate Treasury Investments
Corporate treasury investments represent investments in U.S. Treasury and government agency obligations,
commercial paper, certificates of deposit, other investment grade securities and other investments with original
maturities of greater than three months when purchased. These investments are accounted for as trading securities
in which changes in the fair value of each investment are recorded through investment income (loss). Any interest
earned on debt investments is recorded through interest and other income.
Derivative Instruments
The Company uses derivative instruments primarily to reduce its exposure to changes in foreign currency
exchange rates. Derivative instruments are recognized at fair value in the condensed consolidated balance sheets
with changes in fair value recognized in the condensed consolidated statements of operations for all derivatives not
designated as hedging instruments.
Securities Sold Under Agreements to Repurchase
As it relates to certain European CLOs sponsored by the Company, securities sold under agreements to
repurchase (“Repurchase Agreements”) are accounted for as collateralized financing transactions. The Company
provides securities to counterparties to collateralize amounts borrowed under Repurchase Agreements on terms
that permit the counterparties to repledge or resell the securities to others. As of September 30, 2026,$358.6 million
of securities were transferred to counterparties under Repurchase Agreements and are included within investments
in the condensed consolidated balance sheets. Cash received under Repurchase Agreements is recognized as a
liability within debt obligations in the condensed consolidated balance sheets. See Note 5, Borrowings, for additional
information.
Fixed Assets
Fixed assets consist of furniture, fixtures and equipment, leasehold improvements, computer hardware and
software, and fractional shares in corporate aircraft, and are stated at cost, less accumulated depreciation and
amortization. Depreciation is recognized on a straight-line method over the assets’ estimated useful lives, which for
leasehold improvements are the lesser of the lease terms or the life of the asset, andthree toseven years for other
fixed assets. Fixed assets are reviewed for impairment whenever events or changes in circumstances indicate that
the carrying amount of an asset may not be recoverable.
Leases
The Company accounts for its leases in accordance with ASC 842, Leases, and recognizes a lease liability
and right-of-use (“ROU”) asset in the condensed consolidated balance sheets for contracts that it determines are
leases or contain a lease. The Company’s leases primarily consist of operating leases for office space in various
countries around the world. The Company also has operating leases for office equipment and vehicles, which are
not significant. The Company does not separate non-lease components from lease components for its office space
and equipment operating leases and instead accounts for each separate lease component and its associated non-
lease component as a single lease component. ROU assets represent the Company’s right to use an underlying
asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising
from the leases. The Company’s ROU assets and lease liabilities are recognized at lease commencement based on
the present value of lease payments over the lease term. Lease ROU assets include initial direct costs incurred by
the Company and are presented net of deferred rent and lease incentives. Absent an implicit interest rate in the
lease, the Company uses its incremental borrowing rate, adjusted for the effects of collateralization, based on the
information available at commencement in determining the present value of lease payments. The Company’s lease
terms may include options to extend or terminate the lease when it is reasonably certain that the Company will
exercise those options. Lease expense for lease payments is recognized on a straight-line basis over the lease
term. Lease ROU assets are reviewed for impairment whenever events or changes in circumstances indicate that
the carrying amount of the asset may not be recoverable.
The Company does not recognize a lease liability or ROU asset on the balance sheet for short-term leases.
Instead, the Company recognizes short-term lease payments as an expense on a straight-line basis over the lease
term. A short-term lease is defined as a lease that, at the commencement date, has a lease term of 12 months or
less and does not include an option to purchase the underlying asset that the lessee is reasonably certain to
exercise. When determining whether a lease qualifies as a short-term lease, the Company evaluates the lease term
and the purchase option in the same manner as all other leases.
In 2026, the Company entered into an operating lease agreement for office space in New York City, which has
a term of 10 years and is expected to commence during 2028. The total contractual minimum lease payment over
the term of the lease is approximately$255 million. The related ROU asset and operating lease liability will be
recorded on the lease commencement date and are not reflected on the Company’s condensed consolidated
balance sheets as of September 30, 2026.
Intangible Assets and Goodwill
The Company’s intangible assets consist of acquired contractual rights to earn future fee income, including
management and advisory fees, customer relationships, and acquired trademarks. Finite-lived intangible assets are
amortized over their estimated useful lives, which range from four toeight years, and are reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of the asset may not be
recoverable. Intangible asset amortization expense was$32.8 million for both thethree months ended September
30, 2026 and 2025, and$98.4 million and$98.2 million for thenine months ended September 30, 2026 and 2025,
respectively, and is included in general, administrative, and other expenses in the condensed consolidated
statements of operations. Certain intangible assets are held by entities of which the functional currency is not the
U.S. dollar. Any corresponding currency translation is recorded in accumulated other comprehensive income (loss).
Goodwill represents the excess of cost over the identifiable net assets of businesses acquired and is recorded
in the functional currency of the acquired entity. Goodwill is recognized as an asset and is reviewed for impairment
annually as of October 1 and between annual tests when events and circumstances indicate that impairment may
have occurred.
The Company recordedno impairment losses of intangible assets or goodwill during thethree and nine
months ended September 30, 2026 and 2025.
Deferred Revenue
Deferred revenue represents management fees and other revenue received prior to the balance sheet date,
which has not yet been earned. Deferred revenue also includes transaction and portfolio advisory fees received by
the Company that are required to offset fund management fees pursuant to the related fund agreements.
Accumulated Other Comprehensive Income (Loss)
The Company’s accumulated other comprehensive income (loss)comprises foreign currency translation
adjustments and gains and losses on defined benefit plans sponsored by AlpInvest. The components of
accumulated other comprehensive income (loss) as of September 30, 2026 and December 31, 2025 were as
follows:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Currency translation adjustments | $(194.9) | $(172.7) |
| Unrealized gains on defined benefit plans | 0.7 | 2.5 |
| Total | $(194.2) | $(170.2) |
Foreign Currency Translation
Non-U.S. dollar denominated assets and liabilities are remeasured at period-end rates of exchange, and the
condensed consolidated statements of operations are remeasured at rates of exchange in effect throughout the
period. Foreign currency gains (losses) resulting from transactions outside of the functional currency of an entity of
$1.0 million and$2.9 million for thethree months ended September 30, 2026 and 2025, respectively, and
$3.9 million and$(22.2) million for thenine months ended September 30, 2026 and 2025, respectively, are included
in general, administrative and other expenses in the condensed consolidated statements of operations.
Recent Accounting Pronouncements
The Company considers the applicability and impact of all accounting standard updates (“ASU”) issued by the
Financial Accounting Standards Board (“FASB”). ASUs not listed below were assessed and either determined to be
not applicable or expected to have minimal impact on the Company’s condensed consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which
requires disaggregated disclosures of certain categories of expenses on an annual and interim basis including
employee compensation, depreciation, and intangible asset amortization for each income statement line item that
contains those expenses. The guidance is effective for annual periods beginning after December 15, 2026 and
interim periods beginning after December 15, 2027. The Company is currently evaluating the impact of adopting this
guidance on its condensed consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, Targeted Improvements to the Accounting for Internal-
Use Software, which clarifies the threshold for capitalizing internal-use software costs to be based on when (i)
management has authorized and committed to funding the software project and (ii) it is probable that the project will
be completed and the software will be used to perform the function intended. The guidance is effective for annual
periods beginning after December 15, 2027 and interim periods within those annual reporting periods. Early
adoption is permitted, and the amendments in this update may be applied on a prospective, retrospective or
modified basis. The Company is currently evaluating the impact of adopting this guidance on its condensed
consolidated financial statements.
In September 2026, the FASB issued ASU 2026-03, Investment Companies with Equity Securities Subject to
Contractual Sale Restrictions, which changes how investment companies in the scope of ASC 946, Financial
Services — Investment Companies, measure the fair value of an equity security that is subject to a contractual
restriction that prohibits the sale of the security. The guidance is effective for annual reporting periods beginning
after December 15, 2027, and interim periods within those annual reporting periods. Early adoption is permitted,
and the amendments in this update are required to be applied on a prospective basis. The Company is currently
evaluating the impact of adopting this guidance on its condensed consolidated financial statements.
- Fair Value Measurement
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring
basis by the fair value hierarchy levels as disclosed in Note 2, Summary of Significant Accounting Policies, as of
September 30, 2026:
| (Dollars in millions) | Level I | Level II | Level III | Total |
|---|---|---|---|---|
| Assets | ||||
| Investments of Consolidated Funds(1): | ||||
| Equity securities(2) | $47.1 | $18.7 | $1,174.0 | $1,239.8 |
| Bonds | — | — | 760.2 | 760.2 |
| Loans | — | — | 10,033.9 | 10,033.9 |
| 47.1 | 18.7 | 11,968.1 | 12,033.9 | |
| Investments in CLOs and other: | ||||
| Investments in CLOs | — | — | 293.3 | 293.3 |
| Other investments(3) | 89.7 | 20.2 | 19.0 | 128.9 |
| Subtotal | $136.8 | $38.9 | $12,280.4 | $12,456.1 |
| Investments measured at net asset value | 1,683.3 | |||
| Total | $14,139.4 | |||
| Liabilities | ||||
| Loans payable of Consolidated Funds(4)(5) | $— | $— | $10,755.3 | $10,755.3 |
| Foreign currency forward contracts | — | 2.0 | — | 2.0 |
| Total | $— | $2.0 | $10,755.3 | $10,757.3 |
(1)This balance excludes$1.7 billion of Investments of Consolidated Funds that are included in Investments measured at
net asset value, which relate to certain consolidated investment fund of funds in the Company’s Carlyle AlpInvest
(2)This balance includes$773.6 million related to investments that have been bridged by a subsidiary of the Company to
investment funds and are accounted for as consolidated VIEs as of September 30, 2026. The Company’s subsidiary,
which is accounted for as a consolidated VIE, has entered into warehouse agreements with certain funds to transfer
certain of these investments at a price agreed upon by the parties, which may differ from fair value.
(3)The Level III balance excludes$97.8 million related tofour corporate investments in equity securities which the Company
has elected to account for under the measurement alternative for equity securities without readily determinable fair
values pursuant to ASC 321, Investments–Equity Securities. As a non-recurring fair value measurement, the fair value of
these equity securities is excluded from the tabular Level III rollforward disclosures.
(4)Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO
financial assets, less (i) the fair value ofany beneficial interests held by the Company and (ii) the carrying value of any
(5)Loans payable of Consolidated Funds balance excludes$926.7 million of senior notes measured at amortized cost and a
$33.9 million revolving credit balance, which relate to certain consolidated investment fund of funds in the Company’s
Carlyle AlpInvest segment.
The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring
basis by the above fair value hierarchy levels as of December 31, 2025:
| (Dollars in millions) | Level I | Level II | Level III | Total |
|---|---|---|---|---|
| Assets | ||||
| Investments of Consolidated Funds(1): | ||||
| Equity securities(2) | $132.0 | $18.2 | $1,094.8 | $1,245.0 |
| Bonds | — | — | 691.2 | 691.2 |
| Loans | — | — | 9,249.8 | 9,249.8 |
| 132.0 | 18.2 | 11,035.8 | 11,186.0 | |
| Investments in CLOs and other: | ||||
| Investments in CLOs | — | — | 349.0 | 349.0 |
| Other investments(3) | 112.0 | 20.9 | 94.6 | 227.5 |
| 112.0 | 20.9 | 443.6 | 576.5 | |
| Foreign currency forward contracts | — | 4.8 | — | 4.8 |
| Subtotal | $244.0 | $43.9 | $11,479.4 | $11,767.3 |
| Investments measured at net asset value | 1,340.6 | |||
| Total | $13,107.9 | |||
| Liabilities | ||||
| Loans payable of Consolidated Funds(4)(5) | $— | $— | $9,423.1 | $9,423.1 |
| Foreign currency forward contracts | — | 4.4 | — | 4.4 |
| Total | $— | $4.4 | $9,423.1 | $9,427.5 |
(1)This balance excludes$1.3 billion of Investments of Consolidated Funds that are included in Investments measured at
net asset value, which relate to certain consolidated investment fund of funds in the Company’s Carlyle AlpInvest
(2)This balance includes$989.4 million related to investments that have been bridged by a subsidiary of the Company to
investment funds and are accounted for as consolidated VIEs as of December 31, 2025. The Company’s subsidiary,
which is accounted for as a consolidated VIE, has entered into warehouse agreements with certain funds to transfer
certain of these investments at a price agreed upon by the parties, which may differ from fair value.
(3)The Level III balance excludes$63.0 million related to three corporate investments in equity securities which the
Company has elected to account for under the measurement alternative for equity securities without readily determinable
fair values pursuant to ASC 321, Investments–Equity Securities. As a non-recurring fair value measurement, the fair
value of these equity securities is excluded from the tabular Level III rollforward disclosures.
(4)Senior and subordinated notes issued by CLO vehicles are valued based on the more observable fair value of the CLO
(5)Loans payable of Consolidated Funds balance excludes$939.9 million of senior notes measured at amortized cost and a
$63.0 million revolving credit balance, which relate to certain consolidated investment fund of funds in the Company’s
Carlyle AlpInvest segment.
The changes in financial instruments measured at fair value for which the Company has used Level III inputs
to determine fair value are as follows (Dollars in millions):
| Financial Assets | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended September 30, 2026 | ||||||
| Investments of Consolidated Funds | ||||||
| Equitysecurities | Bonds | Loans | Investments in CLOs | Other investments | Total | |
| Balance, beginning of period | $981.8 | $720.7 | $9,502.2 | $321.0 | $20.0 | $11,545.7 |
| Initial consolidation of funds(1) | (7.4) | 20.0 | 533.9 | (1.0) | — | 545.5 |
| Purchases | 374.8 | 186.4 | 1,631.9 | 13.1 | — | 2,206.2 |
| Sales and distributions | (159.6) | (159.8) | (1,206.1) | (35.8) | — | (1,561.3) |
| Settlements | — | — | (378.6) | — | — | (378.6) |
| Realized and unrealized gains (losses), net | ||||||
| Included in earnings | (15.6) | (3.0) | (25.9) | 0.1 | (1.0) | (45.4) |
| Included in other comprehensive income | — | (4.1) | (23.5) | (4.1) | — | (31.7) |
| Balance, end of period | $1,174.0 | $760.2 | $10,033.9 | $293.3 | $19.0 | $12,280.4 |
| Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $0.7 | $(2.8) | $(3.6) | $0.6 | $(1.0) | $(6.1) |
| Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $— | $(4.2) | $(36.2) | $(4.0) | $— | $(44.4) |
| Financial Assets | ||||||
| Nine Months Ended September 30, 2026 | ||||||
| Investments of Consolidated Funds | ||||||
| Equitysecurities | Bonds | Loans | Investments in CLOs | Other investments | Total | |
| Balance, beginning of period | $1,094.8 | $691.2 | $9,249.8 | $349.0 | $94.6 | $11,479.4 |
| Initial consolidation/deconsolidation of funds(2) | (34.6) | 14.1 | (261.5) | 13.7 | — | (268.3) |
| Purchases | 716.7 | 456.3 | 6,634.8 | 35.9 | 12.5 | 7,856.2 |
| Sales and distributions | (482.3) | (369.6) | (4,194.9) | (93.5) | (86.9) | (5,227.2) |
| Settlements | — | — | (1,154.3) | — | — | (1,154.3) |
| Realized and unrealized gains (losses), net | ||||||
| Included in earnings | (120.6) | (11.5) | (125.1) | (2.0) | (1.2) | (260.4) |
| Included in other comprehensive income | — | (20.3) | (114.9) | (9.8) | — | (145.0) |
| Balance, end of period | $1,174.0 | $760.2 | $10,033.9 | $293.3 | $19.0 | $12,280.4 |
| Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $(110.2) | $(11.8) | $(70.1) | $(1.3) | $(1.0) | $(194.4) |
| Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $— | $(12.6) | $(113.9) | $(9.9) | $— | $(136.4) |
(1)As a result of the initial consolidation oftwo funds during thethree months ended September 30, 2026.
(2)As a result of the initial consolidation ofthree funds and deconsolidation offive funds during thenine months ended
September 30, 2026.
| Financial Assets | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended September 30, 2025 | ||||||
| Investments of Consolidated Funds | ||||||
| Equitysecurities | Bonds | Loans | Investments in CLOs | Other investments | Total | |
| Balance, beginning of period | $910.1 | $569.7 | $7,964.7 | $366.9 | $66.3 | $9,877.7 |
| Initial consolidation/deconsolidation of funds(1) | — | (87.7) | (920.6) | (0.7) | — | (1,009.0) |
| Purchases | 78.6 | 253.0 | 3,601.0 | 27.7 | 0.6 | 3,960.9 |
| Sales and distributions | (11.1) | (102.8) | (2,023.6) | (18.8) | (58.2) | (2,214.5) |
| Settlements | — | — | (529.3) | — | — | (529.3) |
| Realized and unrealized gains (losses), net | ||||||
| Included in earnings | (34.1) | 2.5 | (1.8) | 10.1 | (2.0) | (25.3) |
| Included in other comprehensive income | — | (0.1) | (0.9) | (4.5) | — | (5.5) |
| Balance, end of period | $943.5 | $634.6 | $8,089.5 | $380.7 | $6.7 | $10,055.0 |
| Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $(39.2) | $1.0 | $(1.0) | $8.3 | $(4.7) | $(35.6) |
| Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $— | $0.1 | $0.6 | $(3.9) | $— | $(3.2) |
| Financial Assets | ||||||
| Nine Months Ended September 30, 2025 | ||||||
| Investments of Consolidated Funds | ||||||
| Equitysecurities | Bonds | Loans | Investments in CLOs | Other investments | Total | |
| Balance, beginning of period | $572.0 | $465.1 | $6,431.4 | $378.9 | $85.1 | $7,932.5 |
| Initial consolidation/deconsolidation of funds(2) | — | (140.3) | (1,176.7) | 23.5 | — | (1,293.5) |
| Transfer out related to the Exchange(3) | — | — | — | — | (50.4) | (50.4) |
| Purchases | 406.4 | 536.2 | 7,119.7 | 30.9 | 60.6 | 8,153.8 |
| Sales and distributions | (39.6) | (287.1) | (3,354.0) | (100.6) | (89.4) | (3,870.7) |
| Settlements | — | (0.6) | (1,238.4) | — | — | (1,239.0) |
| Realized and unrealized gains (losses), net | ||||||
| Included in earnings | 4.7 | 6.4 | (62.7) | 23.9 | 0.8 | (26.9) |
| Included in other comprehensive income | — | 54.9 | 370.2 | 24.1 | — | 449.2 |
| Balance, end of period | $943.5 | $634.6 | $8,089.5 | $380.7 | $6.7 | $10,055.0 |
| Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $(1.9) | $2.8 | $(49.1) | $22.8 | $1.0 | $(24.4) |
| Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $— | $26.3 | $193.0 | $24.7 | $— | $244.0 |
(1)As a result of the initial consolidation ofthree funds and deconsolidation ofone fund during thethree months ended
September 30, 2025.
(2)As a result of the initial consolidation offour funds and deconsolidation oftwo funds during thenine months ended
September 30, 2025.
(3)Represents the exchange of the BDC Preferred Shares, which were valued using Level III inputs, for common shares of
CGBD, which were valued using Level I inputs. See Note 9, Related Party Transactions, to our Annual Report on Form 10-
K for the year ended December 31, 2025 for more information.
| Financial Liabilities | ||
|---|---|---|
| Loans Payable of Consolidated Funds | ||
| Three Months Ended September 30, | ||
| 2026 | 2025 | |
| Balance, beginning of period | $9,837.2 | $7,923.0 |
| Initial consolidation/deconsolidation of funds(1) | 582.5 | (521.3) |
| Borrowings | 3,879.7 | 3,446.7 |
| Paydowns | (1,715.5) | (713.9) |
| Sales | (1,770.4) | (1,890.5) |
| Realized and unrealized (gains) losses, net | ||
| Included in earnings | (31.7) | (34.7) |
| Included in other comprehensive income | (26.5) | (0.6) |
| Balance, end of period | $10,755.3 | $8,208.7 |
| Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date | $(30.3) | $(21.4) |
| Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date | $(67.4) | $1.9 |
| Financial Liabilities | ||
| Loans Payable of Consolidated Funds | ||
| Nine Months Ended September 30, | ||
| 2026 | 2025 | |
| Balance, beginning of period | $9,423.1 | $6,809.1 |
| Initial consolidation/deconsolidation of funds(2) | 177.1 | (801.4) |
| Borrowings | 7,986.9 | 5,659.0 |
| Paydowns | (3,355.1) | (1,555.5) |
| Sales | (3,252.7) | (2,243.7) |
| Realized and unrealized (gains) losses, net | ||
| Included in earnings | (95.4) | (74.0) |
| Included in other comprehensive income | (128.6) | 415.2 |
| Balance, end of period | $10,755.3 | $8,208.7 |
| Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date | $(71.3) | $(35.9) |
| Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date | $(197.3) | $452.4 |
(1)As a result of the initial consolidation ofone fund during thethree months ended September 30, 2026, and the
initial consolidation ofthree funds and deconsolidation ofone fund during thethree months ended September 30,
(2)As a result of the initial consolidation offour funds and the deconsolidation offour funds during thenine months
ended September 30, 2026, and the initial consolidation offour fundsand deconsolidation oftwo funds during
thenine months ended September 30, 2025.
Realized and unrealized gains and losses included in earnings for Level III investments for investments in
CLOs and other investments are included in investment income (loss), and such gains and losses for investments of
Consolidated Funds and loans payable of the Consolidated Funds are included in Net investment income of
Consolidated Funds in the condensed consolidated statements of operations.
Gains and losses included in other comprehensive income for all Level III financial assets and liabilities are
included in accumulated other comprehensive loss and non-controlling interests in consolidated entities.
The following table summarizes quantitative information about the Company’s Level III inputs as of
September 30, 2026:
| Fair Value at | Valuation Technique(s) | Unobservable Input(s) | Range(Weighted Average) | Impact to Valuation from Increase in Input | |
|---|---|---|---|---|---|
| (Dollars in millions) | September 30, 2026 | ||||
| Assets | |||||
| Investments of Consolidated Funds: | |||||
| Equity securities | $1.9 | Consensus Pricing | Indicative Quotes ($ per share) | 0.00 - 547.56 (467.64) | Higher |
| 755.1 | Discounted Cash Flow | Discount Rates | 0% - 19% (11%) | Lower | |
| Terminal Growth Rate | 0% - 11% (3%) | Higher | |||
| Comparable Multiple · EBITDA Multiple · 1.2x - 22.7x (13.8x) · Higher | |||||
| Revenue Multiple · 2.8x - 8.6x (5.9x) · Higher | |||||
| 235.7 | Discounted Cash Flow | Discount Rates | 7% - 24% (14%) | Lower | |
| Constant Prepayment Rate | 6% - 18% (8%) | Lower | |||
| Constant Default Rate | 0% - 5% (1%) | Lower | |||
| 181.3 | Other(1) | N/A | N/A | N/A | |
| Bonds | 760.2 | Consensus Pricing | Indicative Quotes (% of Par) | 58 - 101 (95) | Higher |
| Loans | 9,755.0 | Consensus Pricing | Indicative Quotes (% of Par) | 1 - 101 (97) | Higher |
| 277.2 | Discounted Cash Flow | Discount Rates | 8% - 20% (10%) | Lower | |
| Constant Prepayment Rate | 11% - 11% (11%) | Lower | |||
| Constant Default Rate | 2% - 4% (2%) | Lower | |||
| Severity | 75% - 75% (75%) | Higher | |||
| 1.7 | Other(1) | N/A | N/A | N/A | |
| Investments in CLOs: | |||||
| Senior secured notes | 255.9 | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | 80 - 102 (100) | Higher |
| Discount Margins (Basis Points) | 85 - 1,450 (217) | Lower | |||
| Default Rates | 2% - 2% (2%) | Lower | |||
| Recovery Rates | 60% - 60% (60%) | Higher | |||
| Subordinated notes and preferred shares | 37.4 | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | 1 - 82 (28) | Higher |
| Discount Rates | 8% - 19% (11%) | Lower | |||
| Default Rates | 1% - 2% (2%) | Lower | |||
| Recovery Rates | 60% - 60% (60%) | Higher | |||
| Other investments: | |||||
| Aviation subordinated notes | 6.5 | Discounted Cash Flow | Discount Rates | 21% - 21% (21%) | Lower |
| 12.5 | Other(1) | N/A | N/A | N/A | |
| Total | $12,280.4 | ||||
| Liabilities | |||||
| Loans payable of Consolidated Funds: | |||||
| Senior secured notes | $10,172.2 | Other(2) | N/A | N/A | N/A |
| Subordinated notes and preferred shares | 355.1 | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | 3 - 90 (62) | Higher |
| Discount Rates | 7% - 14% (10%) | Lower | |||
| Default Rates | 1% - 2% (2%) | Lower | |||
| Recovery Rates | 60% - 60% (60%) | Higher | |||
| 228.0 | Other(1) | N/A | N/A | ||
| Total | $10,755.3 | ||||
(1)Fair value approximates transaction price that was in close proximity to the reporting date.
(2)Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO
The following table summarizes quantitative information about the Company’s Level III inputs as of
December 31, 2025:
| Fair Value at | Valuation Technique(s) | Unobservable Input(s) | Range(Weighted Average) | Impact to Valuation from Increase in Input | |
|---|---|---|---|---|---|
| (Dollars in millions) | December 31, 2025 | ||||
| Assets | |||||
| Investments of Consolidated Funds: | |||||
| Equity securities | $1.4 | Consensus Pricing | Indicative Quotes ($ per share) | 0.00 - 20.38 (0.19) | Higher |
| 789.2 | Discounted Cash Flow | Discount Rates | 7% - 19% (11%) | Lower | |
| Terminal Growth Rate | 1% - 11% (4%) | Higher | |||
| Comparable Multiple · EBITDA Multiple · 1.5x - 23.8x (12.0x) · Higher | |||||
| Revenue Multiple · 2.8x - 2.8x (2.8x) · Higher | |||||
| TCF Multiple · 22.3x - 22.3x (22.3x) · Higher | |||||
| 112.3 | Discounted Cash Flow | Discount Rates | 7% - 20% (12%) | Lower | |
| Constant Prepayment Rate | 6% - 16% (9%) | Lower | |||
| Constant Default Rate | 0% - 6% (1%) | Lower | |||
| Recovery Rate | 0% - 40% (21%) | Higher | |||
| 191.9 | Other(1) | N/A | N/A | N/A | |
| Bonds | 691.2 | Consensus Pricing | Indicative Quotes (% of Par) | 12 - 106 (96) | Higher |
| Loans | 9,028.5 | Consensus Pricing | Indicative Quotes (% of Par) | 0 - 101 (98) | Higher |
| 216.0 | Discounted Cash Flow | Discount Rates | 6% - 16% (9%) | Lower | |
| 3.5 | Discounted Cash Flow | Discount Rates | 14% - 14% (14%) | Lower | |
| Constant Prepayment Rate | 8% - 14% (11%) | Lower | |||
| Constant Default Rate | 2% - 2% (2%) | Lower | |||
| Other | 1.8 | Other(1) | N/A | N/A | N/A |
| Investments in CLOs | |||||
| Senior secured notes | 303.3 | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | 92 - 101 (100) | Higher |
| Discount Margins (Basis Points) | 80 - 1,060 (204) | Lower | |||
| Default Rates | 2% - 2% (2%) | Lower | |||
| Recovery Rates | 60% - 60% (60%) | Higher | |||
| Subordinated notes and preferred shares | 45.7 | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | 0 - 87 (38) | Higher |
| Discount Rate | 0% - 31% (10%) | Lower | |||
| Default Rates | 1% - 2% (2%) | Lower | |||
| Recovery Rates | 60% - 60% (60%) | Higher | |||
| Other investments: | |||||
| Aviation subordinated notes | 7.5 | Discounted Cash Flow | Discount Rates | 21% - 21% (21%) | Lower |
| Loans | 37.6 | Discounted Cash Flow | Discount Rates | 6% - 10% (9%) | Lower |
| Consensus Pricing | Indicative Quotes (% of Par) | 100 - 100 (100) | Higher | ||
| 49.5 | Other(1) | N/A | N/A | N/A | |
| Total | $11,479.4 | ||||
| Fair Value at | Valuation Technique(s) | Unobservable Input(s) | Range(Weighted Average) | Impact to Valuation from Increase in Input | |
|---|---|---|---|---|---|
| (Dollars in millions) | December 31, 2025 | ||||
| Liabilities | |||||
| Loans payable of Consolidated Funds: | |||||
| Senior secured notes | $9,032.2 | Other(2) | N/A | N/A | N/A |
| Subordinated notes and preferred shares | 390.9 | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | 10 - 84 (51) | Higher |
| Discount Rates | 5% - 24% (9%) | Lower | |||
| Default Rates | 1% - 2% (2%) | Lower | |||
| Recovery Rates | 60% - 60% (60%) | Higher | |||
| Total | $9,423.1 | ||||
(1)Fair value approximates transaction price that was in close proximity to the reporting date.
(2)Senior and subordinated notes issued by CLO vehicles are classified based on the more observable fair value of the CLO
- Investments
Investments consist of the following:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Accrued performance allocations | $5,801.3 | $7,620.3 |
| Principal equity method investments, excluding performance allocations | 3,069.4 | 2,879.5 |
| Principal investments in CLOs | 293.3 | 349.0 |
| Other investments | 236.7 | 303.9 |
| Total | $9,400.7 | $11,152.7 |
Accrued Performance Allocations
The components of accrued performance allocations are as follows:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Global Private Equity | $3,164.8 | $5,021.1 |
| Global Credit | 918.5 | 724.6 |
| Carlyle AlpInvest | 1,718.0 | 1,874.6 |
| Total | $5,801.3 | $7,620.3 |
Approximately 12% of accrued performance allocations at September 30, 2026 were related to Carlyle
Partners VIII, L.P., one of the Company’s Global Private Equity funds. Approximately 24% of accrued performance
allocations at December 31, 2025 were related to Carlyle Partners VII, L.P., one of the Company’s Global Private
Equity funds.
Accrued performance allocations are shown gross of the Company’s accrued performance allocations and
incentive fee related compensation (see Note 6, Accrued Compensation and Benefits) and accrued giveback
obligations, which are separately presented in the condensed consolidated balance sheets, as well as the portion
attributable to non-controlling interests.
The components of the accrued giveback obligations are as follows:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Global Private Equity | $(94.7) | $(47.3) |
| Global Credit | (25.5) | (25.5) |
| Total | $(120.2) | $(72.8) |
Principal Equity Method Investments, Excluding Performance Allocations
The Company’s principal equity method investments (excluding performance allocations) include its fund
investments in Global Private Equity, Global Credit, and Carlyle AlpInvest typically as general partner interests, and
its investments in Fortitude through a Carlyle-affiliated fund (included within Global Credit) and NGP (included within
Global Private Equity), which are not consolidated. Principal investments are related to the following segments:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Global Private Equity(1) | $1,460.5 | $1,384.4 |
| Global Credit(2) | 1,185.0 | 1,151.9 |
| Carlyle AlpInvest | 423.9 | 343.2 |
| Total | $3,069.4 | $2,879.5 |
(1)The balance includes$640.9 million and$616.0 million as of September 30, 2026 and December 31, 2025,
respectively, related to the Company’s equity method investments in NGP.
(2)The balance includes$743.0 million and$722.4 million as of September 30, 2026 and December 31, 2025,
respectively, related to the Company’s investment in Fortitude.
Investment in Fortitude
Carlyle FRL, L.P. (“Carlyle FRL”), a Carlyle-affiliated investment fund, holds a 38.5% interest in FGH Parent,
L.P. (“FGH Parent” or “Fortitude”), an insurance and reinsurance company. The Company indirectly owns 10.5% of
Fortitude, and Carlyle FRL and other strategic third-party investors collectively hold a 97.5% interest in Fortitude. As
of September 30, 2026, the carrying value of the Company’s investment in Carlyle FRL, which is an investment
company that accounts for its investment in Fortitude at fair value, was$743.0 million, relative to equity invested of
$666.8 million.
Fortitude declared and paid dividends of$300.0 million in each of September 2026 and 2025, of which
$31.3 million and$31.4 million, respectively, were distributed to the Company from Carlyle FRL and recognized as
realized principal investment income in the condensed consolidated statements of operations for thethree and nine
months ended September 30, 2026 and 2025.
The Company has an asset management relationship with Fortitude pursuant to which Fortitude committed to
allocate assets in asset management strategies and vehicles of the Company and its affiliates. As of September 30,
2026, Fortitude, its affiliates and certain Fortitude reinsurance counterparties have committed approximately
$27.4 billion of capital to-date to various Carlyle strategies. The Company has a strategic advisory services
agreement in place with certain subsidiaries of Fortitude through Carlyle Insurance Solutions Management L.L.C.
(“CISM”), an investment adviser. Under the agreement, CISM provides Fortitude with certain services, including
business development and growth, transaction origination and execution, and capital management services in
exchange for a recurring management fee based on Fortitude’s general account assets, which adjusts within an
agreed range based on Fortitude’s overall profitability.
Investment in NGP
The Company has equity interests in NGP Management Company, L.L.C. (“NGP Management”), the general
partners of certain carry funds advised by NGP, and principal investments in certain NGP funds as described below.
These investments are included in the Global Private Equity segment. NGP Management serves as the investment
advisor to the NGP Energy Funds. The Company does not control NGP and accounts for its investments in NGP
under the equity method of accounting.
The Company’s investments in NGP as of September 30, 2026 and December 31, 2025 are as follows:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Investment in NGP Management | $220.6 | $247.4 |
| Investments in NGP general partners - accrued performance allocations | 377.1 | 326.2 |
| Principal investments in NGP funds | 43.2 | 42.4 |
| Total investments in NGP | $640.9 | $616.0 |
See Note 4, Investments, to our Annual Report on Form 10-K for the year ended December 31, 2025 for
additional information regarding the restructuring of the terms of the Company’s strategic investment in NGP (the
“Restructuring”). As a result of the Restructuring, thenine months ended September 30, 2025 included a
$92.5 million impairment of the Company’s investment in NGP Management and a$38.0 million reduction in
accrued performance allocations, which were recorded in Principal investment income (loss) in the condensed
consolidated statements of operations and excluded from Distributable Earnings, as defined in Note 14, Segment
Reporting. The Company amortizes basis differences established in connection with the Restructuring as a
reduction to Principal investment income over their estimated useful lives.
Investment in NGP Management. The Company’s equity interests in NGP Management entitle the Company
to an allocation of income equal to 55.0% of the management fee related revenues earned by existing funds prior to
the Restructuring that held an initial closing after December 31, 2024, and up to 55.0% of management fee related
revenues on future NGP funds subsequent to the Restructuring in the aggregate, which are based on a sliding
scale, including all management fees being retained by NGP for the years 2025 through 2028 on such future NGP
funds. The Company records investment income (loss) for its equity income allocation from NGP management fee
related revenues and also records its share of any allocated expenses from NGP Management, expenses
associated with the compensatory elements of the investment, and any impairment charges. The net investment
income (loss) recognized in the Company’s condensed consolidated statements of operations for thethree and nine
months ended September 30, 2026 and 2025 related to its investment in NGP Management were as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Management fee related revenues from NGP Management | $13.4 | $15.0 | $42.0 | $46.5 |
| Expenses related to the investment in NGP Management | (2.8) | (3.6) | (8.4) | (10.8) |
| Amortization of basis differences and impairment of investment in NGP Management | (8.3) | (8.7) | (25.5) | (110.0) |
| Net investment income (loss) from NGP Management | $2.3 | $2.7 | $8.1 | $(74.3) |
Management fee related revenues from NGP Management were primarily driven by NGP XI, NGP XII, and
NGP XIII during thethree and nine months ended September 30, 2026 and 2025. These funds calculate
management fees as 1.5% of the limited partners’ commitments less any return of capital or write-offs during the
investment period. Following the investment period, the basis on which fund management fees are generally
calculated is further reduced by a reserve for future management fees and operating costs.
Investment in the General Partners of NGP Carry Funds. The Company’s investment in the general partners
of the NGP Carry Funds entitles it to up to 47.5% of performance allocations received by NGP Fund general
partners. The Company records its equity income allocation from NGP performance allocations in principal
investment income (loss) from equity method investments rather than performance allocations in its condensed
consolidated statements of operations. The Company recognized net investment earnings(losses) related to these
performance allocations of$49.8 million and$23.8 million for thethree months ended September 30, 2026 and
2025, respectively, and$132.1 million and$22.9 million for thenine months ended September 30, 2026 and 2025,
respectively, in its condensed consolidated statements of operations. Thenine months ended September 30, 2025
included a$38.0 million reduction related to the Restructuring.
Principal Investments in NGP Funds. The Company also holds principal investments in the NGP Carry Funds.
The Company recognized net investment earnings (losses) related to these investments in principal investment
income (loss) in its condensed consolidated statements of operations of$7.0 million and$3.3 million for thethree
months ended September 30, 2026 and 2025, respectively, and$18.2 million and$8.8 million for thenine months
ended September 30, 2026 and 2025, respectively.
Principal Investments in CLOs and Other Investments
Principal investments in CLOs as of September 30, 2026 and December 31, 2025 were$293.2 million and
$349.0 million, respectively, and consisted of investments in CLO senior and subordinated notes. A portion of the
Company’s principal investments in CLOs is collateral to CLO term loans (see Note 5, Borrowings). As of
September 30, 2026 and December 31, 2025, other investments included the Company’s investment in common
shares of CGBD at fair value of$33.3 million and$37.5 million, respectively.
Investment Income (Loss)
The components of investment income (loss) are as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Performance allocations | ||||
| Realized | $211.6 | $49.4 | $569.0 | $499.0 |
| Unrealized | (838.2) | (656.1) | (1,832.0) | (244.0) |
| (626.6) | (606.7) | (1,263.0) | 255.0 | |
| Principal investment income (loss) from equity method investments (excluding performance allocations) | ||||
| Realized | 144.6 | 59.6 | 195.4 | 208.5 |
| Unrealized | (29.1) | 8.4 | 67.1 | (147.8) |
| 115.5 | 68.0 | 262.5 | 60.7 | |
| Principal investment income (loss) from investments in CLOs and other investments | ||||
| Realized | 3.1 | 1.1 | 6.9 | 0.7 |
| Unrealized | 0.7 | 18.6 | (16.5) | 18.4 |
| 3.8 | 19.7 | (9.6) | 19.1 | |
| Total | $(507.3) | $(519.0) | $(1,010.1) | $334.8 |
The performance allocations included in revenues are derived from the following segments:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Global Private Equity | $(669.0) | $(781.4) | $(1,468.9) | $(219.5) |
| Global Credit | 128.7 | 93.3 | 268.0 | 223.1 |
| Carlyle AlpInvest | (86.3) | 81.4 | (62.1) | 251.4 |
| Total | $(626.6) | $(606.7) | $(1,263.0) | $255.0 |
The following tables summarize the funds that are the primary drivers of performance allocations for thethree
and nine months ended September 30, 2026 and 2025, as well as the total revenue recognized, including
performance allocations, fund management fees and principal investment income:
| Three Months Ended September 30, 2026 | Nine Months Ended September 30, 2026 | ||||
|---|---|---|---|---|---|
| (Dollars in millions) · (Dollars in millions) | |||||
| Global Private Equity | Carlyle Partners VII, L.P. | $(783.0) | Global Private Equity | Carlyle Partners VII, L.P. | $(1,770.8) |
| Three Months Ended September 30, 2025 | Nine Months Ended September 30, 2025 | ||||
|---|---|---|---|---|---|
| (Dollars in millions) · (Dollars in millions) | |||||
| Global Private Equity | Carlyle Asia Partners V, L.P. | $(257.2) | Global Private Equity | Carlyle Partners VII, L.P. | $(110.2) |
| Global Private Equity | Carlyle Partners VII, L.P. | $(557.9) | Global Private Equity | Carlyle Asia Partners V, L.P. | $(197.4) |
Carlyle’s income (loss) from its principal equity method investments consists of:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Global Private Equity | $82.0 | $39.4 | $201.5 | $(13.0) |
| Global Credit | 10.2 | 12.8 | 25.3 | 31.5 |
| Carlyle AlpInvest | 23.3 | 15.8 | 35.7 | 42.2 |
| Total | $115.5 | $68.0 | $262.5 | $60.7 |
Investments of Consolidated Funds
The Company consolidates the financial positions and results of operations of certain CLOs in which it is the
primary beneficiary. During thenine months ended September 30, 2026, the Company became the primary
beneficiary ofsix additional CLOs. Investments in Consolidated Funds as of September 30, 2026 and December 31,
2025 also included$773.6 million and$989.4 million, respectively, related to investments that have been bridged by
the Company to investment funds in the Global Private Equity and Carlyle AlpInvest segments that are accounted
for as consolidated VIEs.
There were no individual investments with a fair value greater than five percent of the Company’s total assets
for any period presented.
Interest and Other Income of Consolidated Funds
The components of interest and other income of Consolidated Funds are as follows:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Interest income from investments | $163.2 | $146.9 | $503.0 | $412.4 |
| Other income | 11.8 | 16.5 | 44.2 | 47.4 |
| Total | $175.0 | $163.4 | $547.2 | $459.8 |
Net Investment Income (Loss) of Consolidated Funds
Net investment income (loss) of Consolidated Funds includes net realized gains (losses) from sales of
investments and unrealized gains (losses) resulting from changes in fair value of the Consolidated Funds’
investments. The components of Net investment income (loss) of Consolidated Funds are as follows:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Gains (losses) from investments of Consolidated Funds | $(54.3) | $88.5 | $(156.3) | $100.1 |
| Gains from liabilities of consolidated CLOs | 31.6 | 34.7 | 95.4 | 76.0 |
| Total | $(22.7) | $123.2 | $(60.9) | $176.1 |
The following table presents realized and unrealized gains (losses) earned from investments of the
Consolidated Funds (including consolidated CLOs):
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Net realized gains | $52.3 | $58.5 | $10.7 | $33.6 |
| Net change in unrealized gains (losses) | (106.6) | 30.0 | (167.0) | 66.5 |
| Total | $(54.3) | $88.5 | $(156.3) | $100.1 |
- Borrowings
The Company borrows and enters into credit agreements for its general operating and investment purposes.
The Company’s debt obligations consist of the following:
| As of | ||||
|---|---|---|---|---|
| September 30, 2026 | December 31, 2025 | |||
| BorrowingOutstanding | CarryingValue | BorrowingOutstanding | CarryingValue | |
| (Dollars in millions) | ||||
| CLO Borrowings | $370.4 | $367.7 | $350.1 | $349.4 |
| 3.500% Senior Notes Due 9/19/2029 | 425.0 | 423.7 | 425.0 | 423.4 |
| 5.050% Senior Notes Due 9/19/2035 | 800.0 | 791.8 | 800.0 | 791.1 |
| 5.625% Senior Notes Due 3/30/2043 | 600.0 | 600.5 | 600.0 | 600.5 |
| 5.650% Senior Notes Due 9/15/2048 | 350.0 | 346.8 | 350.0 | 346.7 |
| 4.625% Subordinated Notes Due 5/15/2061 | 500.0 | 486.2 | 500.0 | 485.9 |
| Total debt obligations | $3,045.4 | $3,016.7 | $3,025.1 | $2,997.0 |
Senior Credit Facility
The senior credit facility consists of a$1.0 billion revolving credit facility, which was amended in May 2025 to
extend the maturity date from April 29, 2027 to May 29, 2030. The Company is required to maintain management
fee-earning assets of at least$156.9 billion and a total leverage ratio of less than 4.0 to 1.0, in each case, tested on
a quarterly basis. The Company’s borrowing capacity is subject to the ability of the financial institutions in the
banking syndicate to fulfill their respective obligations under the revolving credit facility. Principal amounts
outstanding under the revolving credit facility accrue interest, at the option of the borrowers, either (a) at an
alternate base rate plus an applicable margin not to exceed 0.50% per annum, or (b) at SOFR (or similar
benchmark rate for non-U.S. dollar borrowings) plus a 0.10% adjustment and an applicable margin not to exceed
1.50% per annum (at September 30, 2026, the interest rate was 5.01%). The Company madeno borrowings under
the revolving credit facility during thethree and nine months ended September 30, 2026 and 2025, and there was
no amount outstanding as of September 30, 2026.
Global Credit Revolving Credit Facility
Certain subsidiaries of the Company are parties to a revolving line of credit, primarily intended to support
certain lending activities within the Global Credit segment. As currently amended, the Global Credit Revolving Credit
Facility provides for a revolving line of credit with a capacity of$300 million, which matures in September 2027, and
a second revolving line of credit with a capacity of$200 million, which the Company amended in August 2026 to
extend the maturity date to August 18, 2027. The Company’s borrowing capacity is subject to the ability of the
financial institutions in the banking syndicate to fulfill their respective obligations under the Global Credit Revolving
Credit Facility. Principal amounts outstanding accrue interest at applicable SOFR or Eurocurrency rates plus an
applicable margin of 2.00% or an alternate base rate plus an applicable margin of 1.00%. During thethree and nine
months ended September 30, 2026 and 2025, the Company madeno borrowings under the Global Credit Revolving
Credit Facility. As of September 30, 2026, there wasno borrowing outstanding under the Global Credit Revolving
Credit Facility.
CLO Borrowings
For certain of the Company’s CLOs, the Company finances a portion of its investment in the CLOs through the
proceeds received from term loans and other financing arrangements with financial institutions. The following table
provides information regarding total outstanding CLO borrowings as of September 30, 2026 and December 31,
2025 (Dollars in millions):
| As of September 30, 2026 | As of December 31, 2025 | |||||
|---|---|---|---|---|---|---|
| BorrowingOutstanding | WeightedAverageInterest Rate | WeightedAverageRemainingMaturity inYears | BorrowingOutstanding | WeightedAverageInterest Rate | WeightedAverageRemainingMaturity inYears | |
| Total CLO borrowings | $370.4 | 5.07% | 10.72 | $350.1 | 4.50% | 9.86 |
The CLO term loans are secured by the Company’s investments in the respective CLO, have a general
unsecured interest in the Carlyle entity that manages the CLO, and generally do not have recourse to any other
Carlyle entity. Interest expense for thethree months ended September 30, 2026 and 2025 was$4.6 million and$3.7
million, respectively. Interest expense for thenine months ended September 30, 2026 and 2025 was$12.6 million
and$11.5 million, respectively. The fair value of the outstanding balance of the CLO term loans at September 30,
2026 approximated par value based on current market rates for similar debt instruments. These CLO term loans are
classified as Level III within the fair value hierarchy.
CLO Repurchase Agreements
The Company is party to master credit facility agreements (the “CLO Financing Facilities”) to finance a portion
of the risk retention investments in certain CLOs managed by the Company. Each transaction entered into under the
CLO Financing Facilities bears interest at a rate based on the weighted average effective interest rate of each class
of securities that have been sold plus a spread agreed upon by the parties. As of September 30, 2026,
$358.6 million was outstanding under the CLO Financing Facilities, which includes€296.0 million ($335.6 million) in
borrowings made in Euro. Additional borrowings may be made on terms agreed upon by the Company and the
counterparty subject to the terms and conditions of the CLO Financing Facilities.
Each transaction entered into under the CLO Financing Facilities provides for payment netting and, in the
case of a default or similar event with respect to the counterparty to the CLO Financing Facilities, provides for
netting across transactions. Generally, upon a counterparty default, the Company can terminate all transactions
under the CLO Financing Facilities and offset amounts it owes in respect of any one transaction against collateral, if
any, or other amounts it has received in respect of any other transactions under the CLO Financing Facilities;
provided, however, that in the case of certain defaults, the Company may only be able to terminate and offset solely
with respect to the transaction affected by the default. During the term of a transaction entered into under the CLO
Financing Facilities, the Company will deliver cash or additional securities acceptable to the counterparty if the
securities sold are in default. Upon termination of a transaction, the Company will repurchase the previously sold
securities from the counterparty at a previously determined repurchase price. The CLO Financing Facilities may be
terminated at any time upon certain defaults or circumstances agreed upon by the parties.
The Repurchase Agreements may result in credit exposure in the event the counterparty to the transaction is
unable to fulfill its contractual obligations. The Company minimizes the credit risk associated with these activities by
monitoring counterparty credit exposure and collateral values. Other than margin requirements, the Company is not
subject to additional terms or contingencies which would expose the Company to additional obligations based upon
the performance of the securities pledged as collateral.
Senior Notes
The Company and certain indirect subsidiaries of the Company have issued long term borrowings in the form
of senior notes, on which interest is payable semi-annually in arrears. The following table provides information
regarding these senior notes (Dollars in millions):
| Interest Expense | |||||||
|---|---|---|---|---|---|---|---|
| Aggregate Principal Amount · Fair Value (1)As of · Three Months EndedSeptember 30, · Nine Months EndedSeptember 30, | |||||||
| September 30, 2026 · December 31, 2025 · 2026 · 2025 · 2026 · 2025 | |||||||
| 3.500% Senior Notes Due 9/19/2029 (2) | $425.0 | $400.3 | $417.8 | $3.8 | $3.8 | $11.5 | $11.5 |
| 5.050% Senior Notes Due 9/19/2035 (3) | 800.0 | 726.3 | 800.9 | 10.3 | 1.3 | 31.0 | 1.3 |
| 5.625% Senior Notes Due 3/30/2043 (4) | 600.0 | 533.3 | 600.7 | 8.4 | 8.4 | 25.3 | 25.3 |
| 5.650% Senior Notes Due 9/15/2048 (5) | 350.0 | 307.6 | 347.5 | 4.9 | 4.9 | 14.9 | 14.9 |
| $27.4 | $18.4 | $82.7 | $53.0 | ||||
(1)Including accrued interest. Fair value is based on indicative quotes and the notes are classified as Level II within
the fair value hierarchy.
(2)Issued in September 2019 at 99.841% of par.
(3)Issued in September 2025 at 99.767% of par.
(4)Issued$400.0 million in aggregate principal at 99.583% of par in March 2013. An additional$200.0 million in
aggregate principal was issued at 104.315% of par in March 2014, and is treated as a single class with the
outstanding$400.0 million in senior notes previously issued.
(5)Issued in September 2018 at 99.914% of par.
The issuers may redeem the senior notes, in whole at any time or in part from time to time, at a price equal to
the greater of (i)100% of the principal amount of the notes being redeemed and (ii) the sum of the present values of
the remaining scheduled payments of principal and interest on any notes being redeemed (less interest accrued to
the date of redemption) discounted to the redemption date on a semiannual basis at the Treasury Rate plus 40
basis points (30 basis points in the case of the 3.500% senior notes and 20 basis points in the case of the 5.050%
senior notes), plus in each case accrued and unpaid interest on the principal amounts being redeemed.
Subordinated Notes
In May 2021, an indirect subsidiary of the Company issued$435.0 million aggregate principal amount of
4.625% Subordinated Notes due May 15, 2061 (the “Subordinated Notes”), on which interest is payable quarterly
accruing from May 11, 2021. In June 2021, an additional$65.0 million aggregate principal amount of these
Subordinated Notes were issued and are treated as a single series with the already outstanding$435.0 million
aggregate principal amount. The Subordinated Notes are unsecured and subordinated obligations of the issuer, and
are fully and unconditionally guaranteed (the “Guarantees”), jointly and severally, on a subordinated basis, by the
Company, each of the Carlyle Holdings partnerships, and CG Subsidiary Holdings L.L.C., an indirect subsidiary of
the Company (collectively, the “Guarantors”). The Consolidated Funds are not guarantors, and as such, the assets
of the Consolidated Funds are not available to service the Subordinated Notes under the Guarantee. The
Subordinated Notes may be redeemed at the issuer’s option, in whole or in part, at any time and from time to time,
prior to their stated maturity, at a redemption price equal to their principal amount plus any accrued and unpaid
interest to, but excluding, the redemption date. If interest due on the Subordinated Notes is deemed to no longer be
deductible in the U.S., the Subordinated Notes may be redeemed, in whole, but not in part, within 120 days of the
occurrence of such event at a redemption price equal to their principal amount plus accrued and unpaid interest to,
but excluding, the redemption date.
As of September 30, 2026 and December 31, 2025, the fair value of the Subordinated Notes was
$301.4 million and$342.0 million, respectively. Fair value is based on active market quotes and the notes are
classified as Level I within the fair value hierarchy. For both thethree months ended September 30, 2026 and 2025,
the Company incurred$5.8 million of interest expense on the Subordinated Notes. For both thenine months ended
September 30, 2026 and 2025, the Company incurred$17.6 million of interest expense on the Subordinated Notes.
Debt Covenants
The Company is subject to various financial and non-financial covenants under its loan agreements and the
indentures governing its senior notes. The Company was in compliance with all financial and non-financial
covenants under its various loan agreements as of September 30, 2026.
Loans Payable of Consolidated Funds
Loans payable of Consolidated Funds primarily represent amounts due to holders of debt securities issued by
the CLOs. As of September 30, 2026 and December 31, 2025, the following borrowings were outstanding (Dollars in
millions):
| As of September 30, 2026 | |||||
|---|---|---|---|---|---|
| BorrowingOutstanding · Fair Value · WeightedAverageInterest Rate · WeightedAverageRemainingMaturity inYears | |||||
| Senior secured notes(1) | $11,120.6 | $11,099.0 | 5.05% | 11.87 | |
| Subordinated notes | 449.1 | 355.1 | N/A | (3) | 10.44 |
| Revolving credit facilities(2) | 261.9 | 261.9 | 4.74% | 0.46 | |
| Total | $11,831.6 | $11,716.0 | |||
| As of December 31, 2025 | |||||
|---|---|---|---|---|---|
| BorrowingOutstanding · Fair Value · WeightedAverageInterest Rate · WeightedAverageRemainingMaturity inYears | |||||
| Senior secured notes(1) | $9,994.8 | $9,972.1 | 5.09% | 11.18 | |
| Subordinated notes | 509.6 | 390.9 | N/A | (3) | 9.65 |
| Revolving credit facilities(2) | 63.0 | 63.0 | 6.68% | 3.45 | |
| Total | $10,567.4 | $10,426.0 | |||
(1)Borrowing Outstanding as of September 30, 2026 includes $937.5 million of senior secured notes that are measured at
amortized cost, which approximates fair value. Fair Value as of September 30, 2026 and December 31, 2025 includes
the carrying value of these notes of$926.7 million and$939.9 million, respectively. These senior secured notes were
classified as Level III within the fair value hierarchy.
(2)Fair Value as of September 30, 2026 and December 31, 2025 reflects the amortized cost of outstanding revolving credit
balances which approximates fair value.
(3)The subordinated notes do not have contractual interest rates, but instead receive distributions from the excess cash
flows of the CLOs.
Loans payable of the CLOs are collateralized by the assets held by the CLOs and the assets of one CLO may
not be used to satisfy the liabilities of another. This collateral consisted of cash and cash equivalents, corporate
loans, corporate bonds and other securities. The Company is not liable forany loans payable of the CLOs. As of
September 30, 2026 and December 31, 2025, total assets of the CLOs were$11.8 billion and$11.0 billion,
respectively.
- Accrued Compensation and Benefits
Accrued compensation and benefits consist of the following:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Accrued performance allocations and incentive fee related compensation | $4,037.7 | $5,111.8 |
| Accrued bonuses | 192.7 | 294.5 |
| Realized performance allocations and incentive fee related compensation not yet paid | 210.4 | 315.1 |
| Other | 129.1 | 128.0 |
| Total | $4,569.9 | $5,849.4 |
The following table presents realized and unrealized performance allocations and incentive fee related
compensation:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Realized | $203.3 | $62.9 | $492.2 | $505.2 |
| Unrealized | (537.8) | (387.5) | (1,101.0) | (214.8) |
| Total | $(334.5) | $(324.6) | $(608.8) | $290.4 |
- Commitments and Contingencies
Capital Commitments
The Company and its unconsolidated affiliates have unfunded commitments totaling $4.3 billion as of
September 30, 2026, of which approximately$3.2 billion is subscribed individually by senior Carlyle professionals,
advisors and other professionals. In addition to these unfunded commitments, the Company may from time to time
exercise its right to purchase additional interests in its investment funds that become available in the ordinary
course of their operations.
Under the Carlyle Global Capital Markets platform, certain subsidiaries of the Company may act as an
underwriter, syndicator or placement agent for security offerings and loan originations. The Company earns fees in
connection with these activities and bears the risk of the sale of such securities and placement of such loans, which
may be longer dated. As of September 30, 2026, the Company had no material commitments related to the
origination and syndication of loans and securities under the Carlyle Global Capital Markets platform.
Guaranteed Loans
From time to time, the Company or its subsidiaries may enter into agreements to guarantee certain obligations
of the investment funds related to, for example, credit facilities or equity commitments. Certain consolidated
subsidiaries of the Company are the guarantors of revolving credit facilities for certain funds in the Carlyle AlpInvest
segment. The guarantee is limited to the lesser of the total amount drawn under the credit facilities or the total of net
asset value of the guarantor subsidiaries plus any uncalled capital of the applicable general partner. The
outstanding balances are secured by uncalled capital commitments from the underlying funds, and the Company
believes the likelihood of any material funding under this guarantee to be remote. As of September 30, 2026, the
Company hadno material outstanding guarantees under the credit facilities.
In February 2026, the Company entered into an agreement pursuant to which it provided support for a credit
facility of a certain fund in the Global Credit segment. The maximum aggregate amount that could be funded under
this agreement was approximately$120.0 million as of September 30, 2026. Theagreement will remain effective for
the term of the credit facility, including any extensions thereof, unless terminated earlier in accordance with the
terms of the credit facility. The Company has not funded any amounts under this agreement to date and believes the
likelihood of any material funding to be remote.
In June 2026, certain consolidated subsidiaries of the Company are the guarantors of a credit agreement for a
fund in the Carlyle AlpInvest segment, which is scheduled to expire on December 16, 2026. The maximum potential
amount to be funded under this guarantee is$30.0 million. The outstanding balances under the credit agreement
are collateralized by the investments in the fund, and the Company believes the likelihood of any material funding
under this guarantee to be remote.
In July 2026, the Company entered into an agreement with a financial institution pursuant to which it provided
the guarantee for an unsecured revolving credit facility of an investment fund that is actively fundraising in the
Global Private Equity segment. The maximum aggregate amount available under the facility is$400.0 million, with
$228.0 million outstanding as of September 30, 2026. This facility matures in April 2027 with the possibility to extend
to July 2027. The Company has not funded any amounts under this guarantee to date and believes the likelihood of
any material funding to be remote.
Contingent Obligations
Giveback
A liability for potential repayment of previously received performance allocations of$120.2 million and$72.8
million at September 30, 2026 and December 31, 2025, respectively, is shown as accrued giveback obligations in
the condensed consolidated balance sheets, representing the giveback obligation that would need to be paid if the
funds were liquidated at their current fair values at September 30, 2026 and December 31, 2025, respectively.
However, the ultimate giveback obligation, if any, generally is not paid until the end of a fund’s life or earlier if the
giveback becomes fixed and early payment is agreed upon by the fund’s partners (see Note 2, Summary of
Significant Accounting Policies). The Company had$51.7 million and$24.2 million of unbilled receivables from
former and current employees and senior Carlyle professionals as of September 30, 2026 and December 31, 2025,
respectively, related to giveback obligations. Any such receivables are collateralized by investments made by
individual senior Carlyle professionals and employees in Carlyle-sponsored funds. In addition, as of September 30,
2026 and December 31, 2025,$160.9 million and$151.5 million, respectively, have been withheld from distributions
of carried interest to senior Carlyle professionals and employees for potential giveback obligations. Such amounts
are held on behalf of the respective current and former Carlyle employees to satisfy any givebacks they may owe
and are held by entities not included in the accompanying condensed consolidated balance sheets. Current and
former senior Carlyle professionals and employees are personally responsible for their giveback obligations. As of
September 30, 2026, approximately$51.7 million of the Company’s accrued giveback obligation is the responsibility
of various current and former senior Carlyle professionals and other former limited partners of the Carlyle Holdings
partnerships, and the net accrued giveback obligation attributable to the Company is$68.5 million.
If, at September 30, 2026, all of the investments held by the Company’s Funds were deemed worthless, a
possibility that management views as remote, the amount of realized and distributed carried interest subject to
potential giveback would be$1.5 billion, on an after-tax basis where applicable, of which approximately$0.5 billion
would be the responsibility of current and former senior Carlyle professionals.
Other
In April 2026, in connection with an investment fund that is actively fundraising in the Global Private Equity
segment, the Company entered into an arrangement with a third party pursuant to which the third party subscribed
for a$500.0 million commitment in the investment fund (the “Warehoused Interests”), with the Company obligated to
acquire any unsold Warehoused Interests as of December 31, 2026. As of September 30, 2026,$450.2 million of
Warehoused Interests had been sold to other investors, and the remaining$49.8 million continued to be held by the
third party. In October 2026, the remaining Warehoused Interests were sold to other investors.
In connection with a consolidated investment fund in the Carlyle AlpInvest segment, the Company entered into
an arrangement with a third party pursuant to which the Company may be required to make payments up to
$50.0 million in the aggregate in the event the fund does not achieve a specified return. As of September 30, 2026,
the Company has concluded that the likelihood of payment under this arrangement is not probable; therefore, no
liability has been recorded.
Legal Matters
In the ordinary course of business, the Company is a party to litigation, investigations, inquiries, employment-
related matters, disputes, and other potential claims. Certain of these matters are described below. The Company is
not currently able to estimate the reasonably possible amount of loss or range of loss, in excess of amounts
accrued, for the matters that have not been resolved. Although it is not possible to predict the ultimate outcome of
these unresolved matters, the Company does not believe it is probable that the outcome of any existing litigation,
investigations, disputes, or claims will materially affect the Company or these financial statements in excess of
amounts accrued.
The Tax Receivable Agreement Matter
The Company came into existence on January 1, 2020, when its predecessor, The Carlyle Group L.P. (the
“PTP”), converted from a partnership into a corporation(the “Conversion”). On July 29, 2022, an alleged stockholder
of the Company, the City of Pittsburgh Comprehensive Municipal Trust Fund (the “original Plaintiff”), filed suit in the
Delaware Court of Chancery, alleging a direct claim against the Company for breach of its certificate of
incorporation and a derivative claim on behalf of the Company against certain current and former officers and
directors of the Company. As the original Plaintiff did not actually own shares on the date of the Conversion, it
stipulated to the dismissal of the derivative claims in October of 2025 and the Court has allowed Charles Blackburn
(together with the original Plaintiff, “Plaintiffs”) to intervene as a new plaintiff with respect to the derivative claims.
The original Plaintiff continues as a plaintiff with respect to one direct claim.
Plaintiffs challenge the receipt, by certain officers of the PTP and certain directors of the general partner of the
PTP, of a right to cash payments associated with the elimination of a tax receivable agreement in connection with
the Conversion. Plaintiffs are seeking monetary damages, restitution, and an injunction preventing the Company
from making any future cash payments for the elimination of the tax receivable agreement in connection with the
Conversion. By virtue of the derivative nature of the primary claims (i.e., that the claims are aimed primarily at
certain officers and directors), it is unlikely that the Company itself will pay material damage awards based on the
derivative claims, although the Company is expected to incur legal defense fees to the extent not covered by
insurance. The Delaware Court issued a ruling on the defendants’ motion to dismiss on April 24, 2024, dismissing
some of the original Plaintiff’s claims but allowing most of the claims to proceed to discovery and possibly to trial.
Plaintiffs filed a consolidated amended complaint on November 17, 2025. Defendants filed a motion to dismiss the
consolidated amended complaint on January 16, 2026, which remains pending. The Company intends to continue
to contest the direct claims vigorously, and the officer and director defendants intend to continue contesting the
derivative claims vigorously.
General
The Company currently is and expects to continue to be, from time to time, subject to examinations, formal
and informal inquiries, and investigations by various U.S. and non-U.S. governmental and regulatory agencies,
including but not limited to, the SEC, Department of Justice, state attorneys general, FINRA, National Futures
Association, and the U.K. Financial Conduct Authority. The Company routinely cooperates with such examinations,
inquiries and investigations, and they may result in the commencement of civil, criminal, or administrative or other
proceedings against the Company or its personnel.
It is not possible to predict the ultimate outcome of all pending investigations and legal proceedings and
employment-related matters, and some of the matters discussed above involve claims for potentially large and/or
indeterminate amounts of damages. Based on information known by management, management does not believe
that as of the date of this filing the final resolutions of the matters above will have a material effect upon the
Company’s condensed consolidated financial statements. However, given the potentially large and/or indeterminate
amounts of damages sought in certain of these matters and the inherent unpredictability of investigations and
litigations, it is possible that an adverse outcome in certain matters could, from time to time, have a material effect
on the Company’s financial results in any particular period.
The Company accrues an estimated loss contingency liability when it is probable that such a liability has been
incurred and the amount of the loss can be reasonably estimated. The Company evaluates its outstanding legal and
regulatory proceedings and other matters each quarter to assess its loss contingency accruals, and makes
adjustments in such accruals, upward or downward, as appropriate, based on management’s best judgment after
consultation with counsel. There is no assurance that the Company’s accruals for loss contingencies will not need to
be adjusted in the future or that, in light of the uncertainties involved in such matters, the ultimate resolution of these
matters will not significantly exceed the accruals that the Company has recorded.
Indemnifications
In the normal course of business, the Company and its subsidiaries enter into contracts that contain a variety
of representations and warranties and provide general indemnifications. The Company’s maximum exposure under
these arrangements is unknown as this would involve future claims that may be made against the Company that
have not yet occurred. However, based on experience, the Company believes the risk of material loss to be remote.
In connection with the sale of the Company’s interest in its local Brazilian management entity in August 2021,
the Company provided a guarantee to the acquiring company of up to BRL 100.0 million ($19.3 million as of
September 30, 2026) for liabilities arising from tax-related indemnifications. This guarantee, which will expire in
August 2027, would only come into effect after all alternative remedies have been exhausted. The Company
believes the likelihood of any material funding under this guarantee to be remote.
Risks and Uncertainties
Carlyle’s funds seek investment opportunities that offer the possibility of attaining substantial capital
appreciation. Certain events particular to each industry in which the underlying investees conduct their operations,
as well as general economic, political, regulatory, and public health conditions, may have a significant negative
impact on the Company’s investments and profitability. The funds managed by the Company may also experience a
slowdown in the deployment of capital, which could adversely affect the Company’s ability to raise capital for new or
successor funds and could also impact the management fees the Company earns on its carry funds and managed
accounts, and/or result in the impairment of intangible assets and/orgoodwill in the case of the Company’s acquired
businesses. Such events are beyond the Company’s control, and the likelihood that they may occur and the effect
on the Company cannot be predicted.
Furthermore, certain of the funds’ investments are made in private companies and there are generally no
public markets for the underlying securities at the current time. The funds’ ability to liquidate their publicly traded
investments is often subject to limitations, including discounts that may be required to be taken on quoted prices
due to the number of shares being sold. The funds’ ability to liquidate their investments and realize value is subject
to significant limitations and uncertainties, including among others currency fluctuations and natural disasters.
The Company and the funds make investments outside of the United States. Investments outside the United
States may be subject to less developed bankruptcy, corporate, partnership and other laws (which may have the
effect of disregarding or otherwise circumventing the limited liability structures potentially causing the actions or
liabilities of one fund or a portfolio company to adversely impact the Company or an unrelated fund or portfolio
company). Non-U.S. investments are subject to the same risks associated with the Company’s U.S. investments as
well as additional risks, such as fluctuations in foreign currency exchange rates, unexpected changes in regulatory
requirements, heightened risk of political and economic instability, difficulties in managing non-U.S. investments,
potentially adverse tax consequences, and the burden of complying with a wide variety of foreign laws.
Furthermore, Carlyle is exposed to economic risk concentrations related to certain large investments as well
as concentrations of investments in certain industries and geographies.
Additionally, the Company encounters credit risk. Credit risk is the risk of default by a counterparty in the
Company’s investments in debt securities, loans, leases, and derivatives that result from a borrower’s, lessee’s, or
derivative counterparty’s inability or unwillingness to make required or expected payments. The Company is subject
to credit risk should a financial institution be unable to fulfill its obligations.
The Company considers cash, cash equivalents, securities, receivables, principal equity method investments,
accounts payable, accrued expenses, other liabilities, loans, senior notes, assets, and liabilities of Consolidated
Funds and contingent and other consideration for acquisitions to be its financial instruments. Except for the senior
notes, subordinated notes, and compensatory contingent and other consideration for acquisitions, the carrying
amounts reported in the condensed consolidated balance sheets for these financial instruments equal or closely
approximate their fair values. The fair value of the senior and subordinated notes is disclosed in Note 5, Borrowings.
- Related Party Transactions
Due from Affiliates and Other Receivables, Net
The Company had the following due from affiliates and other receivables at September 30, 2026 and
December 31, 2025:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Accrued incentive fees | $55.5 | $53.6 |
| Unbilled receivable for giveback obligations from current and former employees | 51.7 | 24.2 |
| Notes receivable and accrued interest from affiliates | 51.2 | 34.0 |
| Management fee receivable, net | 251.9 | 246.0 |
| Reimbursable expenses and other receivables from unconsolidated funds and affiliates, net | 605.6 | 477.0 |
| Total | $1,015.9 | $834.8 |
Reimbursable expenses and other receivables from certain of the unconsolidated funds and portfolio
companies relate to advisory fees receivable and expenses paid on behalf of these entities. These costs generally
represent costs related to the pursuit of actual or proposed investments, professional fees, and expenses
associated with the acquisition, holding, and disposition of the investments. The affiliates are obligated at the
discretion of the Company to reimburse the expenses. Based on management’s determination, the Company may
accrue and charge interest on amounts due from affiliate accounts at interest rates ranging up to 7.05% as of
September 30, 2026. The accrued and charged interest to the affiliates was not significant for any period presented.
Notes receivable includes loans that the Company has provided to certain unconsolidated funds to meet short-
term obligations to purchase investments. Notes receivable as of September 30, 2026 and December 31, 2025 also
include interest-bearing loans of$39.2 million and $19.5 million, respectively, to certain eligible Carlyle employees,
which excludes Section 16 officers and other members of senior management, to finance their investments in
certain Carlyle sponsored funds. These advances accrue interest at rates which range between 5.05% and 6.00%
as of September 30, 2026.
These receivables are assessed regularly for collectability. Management fee receivable amounts determined
to be uncollectible are recorded as a reduction in revenue in the condensed consolidated statements of operations.
For all other receivables, amounts determined to be uncollectible are charged directly to general, administrative and
other expenses in the condensed consolidated statements of operations. A corresponding allowance for doubtful
accounts is recorded and such amounts were not significant for any period presented.
Due to Affiliates
The Company has recorded obligations for amounts due to certain of its affiliates. The Company periodically
offsets expenses it has paid on behalf of its affiliates against these obligations. The Company had the following due
to affiliates balances at September 30, 2026 and December 31, 2025:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Due to affiliates of Consolidated Funds | $7.2 | $6.1 |
| Due to non-consolidated affiliates | 126.9 | 102.0 |
| Amounts owed under the tax receivable agreement | 63.7 | 71.8 |
| Other | 20.1 | 24.0 |
| Total | $217.9 | $203.9 |
In connection with the Company’s initial public offering, the Company entered into a tax receivable agreement
with the limited partners of the Carlyle Holdings partnerships whereby certain subsidiaries of the Partnership agreed
to pay to the limited partners of the Carlyle Holdings partnerships involved in any exchange transaction 85% of the
amount of cash tax savings, if any, in U.S. federal, state and local income tax realized as a result of increases in tax
basis resulting from exchanges of Carlyle Holdings Partnership units for common units of The Carlyle Group L.P.
Other Related Party Transactions
Aircraft Transactions
Entities controlled by our co-founders own aircraft that may be used for the Company’s business in the
ordinary course of its operations. The hourly rates that the Company pays for the use of these aircraft are based on
current market rates for chartering private aircraft of the same type. For thethree months ended September 30,
2026 and 2025, the Company incurred fees for the use of these aircraft of $1.0 million and $0.4 million, respectively.
For thenine months ended September 30, 2026 and 2025, the Company incurred fees for the use of these aircraft
of $1.9 million and $1.4 million, respectively. All payments were paid directly to the manager of the aircraft, and a
significant portion of the payments were ultimately paid to or were for the benefit of certain co-founders.
Other Transactions
Senior Carlyle professionals and employees are permitted to participate in co-investment entities that invest in
Carlyle funds or alongside Carlyle funds. In many cases, participation is limited by law to individuals who qualify
under applicable legal requirements. These co-investment entities generally do not require senior Carlyle
professionals and employees to pay management fees or performance allocations, however, Carlyle professionals
and employees are required to pay their portion of partnership expenses.
Carried interest income from certain funds can be distributed to senior Carlyle professionals and employees
on a current basis, but is subject to repayment by the subsidiary of the Company that acts as general partner of the
fund in the event of a realized giveback obligation. The senior Carlyle professionals and certain other investment
professionals have personally guaranteed, subject to certain limitations, the obligation of these subsidiaries in
respect of this general partner obligation. Such guarantees are several and not joint and are limited to a particular
individual’s distributions received.
The Company does business with some of its portfolio companies; all such arrangements are on a negotiated
basis.
Substantially all revenue is earned from affiliates of Carlyle.
- Income Taxes
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Provision (benefit) for income taxes | $(0.1) | $(26.7) | $11.8 | $98.2 |
| Effective tax rate | 0% | (31)% | 66% | 14% |
The effective tax rate for the three and nine months ended September 30, 2026 and 2025 primarily comprised
the 21% U.S. federal corporate income tax rate, the impact of U.S. state and foreign income taxes, the tax effects of
non-controlling interest, disallowed executive compensation, and equity-based compensation deductions. The
effective tax rate for the three months ended September 30, 2026 was 0% due to the offsetting effects of these rate
drivers and the benefit from non-taxable income. The effective tax rate for the three months ended September 30,
2025 was negative primarily due to the tax benefit from the pretax loss incurred prior to the effect of non-controlling
interest and due to the deduction related to the excess tax benefit from the vesting of restricted stock units in the
quarter. For the nine months ended September 30, 2026, the effective tax rate also included the impact of a one-
time tax expense related to a change in the tax classification of a consolidated subsidiary.
As of September 30, 2026 and December 31, 2025, the Company had federal, state, local and foreign taxes
payable of$82.7 million and$141.4 million, respectively, which is recorded as a component of accounts payable,
accrued expenses and other liabilities on the accompanying condensed consolidated balance sheets.
In the normal course of business, the Company is subject to examination by federal and certain state, local
and foreign tax regulators. As of September 30, 2026, the Company’s U.S. federal income tax returns for the years
2022 through 2025 are generally open under the normal three-year statute of limitations and therefore subject to
examination. State and local tax returns are generally subject to audit from 2020 to 2025. Foreign tax returns are
generally subject to audit from 2011 to 2025. Certain of the Company’s affiliates are currently under audit by federal,
state and foreign tax authorities. The Company does not believe that the outcome of the audits will require it to
record material reserves for uncertain tax positions or that the outcome will have a material impact on the
condensed consolidated financial statements.
On October 8, 2021, the OECD introduced a 15% global minimum tax under the Pillar Two GloBE model rules.
On January 5, 2026, the OECD announced a “side-by-side” system under which U.S.-parented groups would be
able to elect to be exempt from certain Pillar Two provisions. Additional guidance on the “side-by-side” system and
implementation of such system remain subject to further discussions and clarifications from the OECD and local
implementation by each OECD member country. Pillar Two has not had a material impact to the Company’s
provision for income taxes; however, the Company will continue to monitor as additional guidance is released by the
OECD, OECD member countries based on their enacted law changes, and other standard-setting bodies.
- Non-controlling Interests in Consolidated Entities
The components of the Company’s non-controlling interests in consolidated entities are as follows:
| As of | ||
|---|---|---|
| September 30, 2026 | December 31, 2025 | |
| (Dollars in millions) | ||
| Non-Carlyle interests in Consolidated Funds | $1,099.9 | $861.5 |
| Non-Carlyle interests in majority-owned subsidiaries | 469.8 | 433.9 |
| Non-controlling interests in carried interest and giveback obligations | 25.4 | 0.2 |
| Non-controlling interests in consolidated entities | $1,595.1 | $1,295.6 |
The components of the Company’s non-controlling interests in income (loss) of consolidated entities are as
follows:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Non-Carlyle interests in Consolidated Funds | $(25.5) | $91.3 | $31.3 | $113.2 |
| Non-Carlyle interests in majority-owned subsidiaries | (2.8) | 20.3 | 38.8 | 35.6 |
| Non-controlling interests in carried interest and giveback obligations | (40.8) | — | (61.2) | (0.2) |
| Non-controlling interests in income (loss) of consolidated entities | $(69.1) | $111.6 | $8.9 | $148.6 |
- Earnings Per Common Share
Basic and diluted net income (loss) per common share are calculated as follows:
| Three Months EndedSeptember 30, 2026 | Nine Months EndedSeptember 30, 2026 | |||
|---|---|---|---|---|
| Basic | Diluted | Basic | Diluted | |
| Net loss attributable to common shares | $(7,700,000) | $(7,700,000) | $(2,800,000) | $(2,800,000) |
| Weighted-average common shares outstanding | 354,291,958 | 354,291,958 | 357,067,726 | 357,067,726 |
| Net loss per common share | $(0.02) | $(0.02) | $(0.01) | $(0.01) |
| Three Months EndedSeptember 30, 2025 | Nine Months EndedSeptember 30, 2025 | |||
|---|---|---|---|---|
| Basic | Diluted | Basic | Diluted | |
| Net income attributable to common shares | $900,000 | $900,000 | $450,600,000 | $450,600,000 |
| Weighted-average common shares outstanding | 360,065,837 | 376,487,705 | 359,965,320 | 369,932,801 |
| Net income per common share | $0.00 | $0.00 | $1.25 | $1.22 |
The weighted-average common shares outstanding, basic and diluted, are calculated as follows:
| Three Months EndedSeptember 30, 2026 | Nine Months EndedSeptember 30, 2026 | |||
|---|---|---|---|---|
| Basic | Diluted | Basic | Diluted | |
| The Carlyle Group Inc. weighted-average common shares outstanding | 354,291,958 | 354,291,958 | 357,067,726 | 357,067,726 |
| Weighted-average common shares outstanding | 354,291,958 | 354,291,958 | 357,067,726 | 357,067,726 |
| Three Months EndedSeptember 30, 2025 | Nine Months EndedSeptember 30, 2025 | |||
|---|---|---|---|---|
| Basic | Diluted | Basic | Diluted | |
| The Carlyle Group Inc. weighted-average common shares outstanding | 360,065,837 | 360,065,837 | 359,965,320 | 359,965,320 |
| Unvested restricted stock units | — | 6,763,578 | — | 6,287,811 |
| Issuable common shares and performance-vesting restricted stock units | — | 9,658,290 | — | 3,679,670 |
| Weighted-average common shares outstanding | 360,065,837 | 376,487,705 | 359,965,320 | 369,932,801 |
The Company applies the treasury stock method to determine the dilutive weighted-average common shares
represented by the unvested restricted stock units. Also included in the determination of dilutive weighted-average
common shares are issuable common shares associated with the Company’s investment in NGP and performance-
vesting restricted stock units. For thethree and nine months ended September 30, 2026, all such awards are
antidilutive and excluded from the computation of diluted earnings per share given the net loss attributable to
common shareholders.
- Equity
Share Repurchase Program
The Board of Directors reset the total repurchase authorization of the Company’s previously approved share
repurchase program to$2.0 billion in shares of the Company’s common stock, effective as of February 26, 2026.
Under the share repurchase program, shares of the Company’s common stock may be repurchased from time to
time in open market transactions, in privately negotiated transactions, or otherwise, including through Rule 10b5-1
plans. The timing and actual number of shares of common stock repurchased will depend on a variety of factors,
including legal requirements and price, economic, and market conditions. In addition to repurchases of common
stock, the share repurchase program is used for the payment of tax withholding amounts upon net share settlement
of equity-based awards granted pursuant to our Equity Incentive Plan or otherwise based on the value of shares
withheld that would have otherwise been issued to the award holder. The share repurchase program may be
suspended or discontinued at any time and does not have a specified expiration date. As of September 30, 2026,
$1.4 billion of repurchase capacity remained under the program, which reflects both common shares repurchased
and shares retired in connection with the net share settlement of equity-based awards. The following table presents
the Company’s shares that have been repurchased or retired as a result of net share settlement of equity-based
awards during thethree and nine months ended September 30, 2026 and 2025. Dollar amounts exclude the impact
of excise taxes.
| Three Months Ended September 30, · Nine Months Ended September 30, | ||||||||
|---|---|---|---|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |||||
| Shares | $ | Shares | $ | Shares | $ | Shares | $ | |
| (Dollars in millions, except share data) | ||||||||
| Shares repurchased | 2,637,455 | $125.0 | 1,568,399 | $100.0 | 10,554,697 | $490.0 | 4,236,146 | $225.0 |
| Shares retired in connection with the net share settlement of equity-based awards | 1,854,503 | 85.4 | 1,693,158 | 102.7 | 4,406,553 | 229.3 | 4,620,513 | 257.8 |
| Total | 4,491,958 | $210.4 | 3,261,557 | $202.7 | 14,961,250 | $719.3 | 8,856,659 | $482.8 |
Dividends
The table below presents information regarding the quarterly dividends on the common shares, which were
made at the sole discretion of the Board of Directors of the Company.
| Dividend Record Date | Dividend Payment Date | Dividend per Common Share | Dividend to Common Shareholders |
|---|---|---|---|
| (Dollars in millions, except per share data) | |||
| May 19, 2025 | May 27, 2025 | $0.35 | $126.3 |
| August 18, 2025 | August 28, 2025 | 0.35 | 126.5 |
| November 10, 2025 | November 19, 2025 | 0.35 | 125.9 |
| February 16, 2026 | February 20, 2026 | 0.35 | 126.4 |
| Total 2025 Dividend Year | $1.40 | $505.1 | |
| May 18, 2026 | May 28, 2026 | $0.35 | $125.7 |
| August 17, 2026 | August 26, 2026 | 0.35 | 124.5 |
| November 16, 2026 | November 23, 2026 | 0.35 | 123.9 |
| Total 2026 Dividend Year (through Q3 2026) | $1.05 | $374.1 | |
The Board of Directors will take into account general economic and business conditions, as well as the
Company’s strategic plans and prospects, business and investment opportunities, financial condition and
obligations, legal, tax, and regulatory restrictions, other constraints on the payment of dividends by the Company to
its common shareholders or by subsidiaries to the Company, and other such factors as the Board of Directors may
deem relevant. In addition, the terms of the Company’s credit facility provide certain limits on the Company’s ability
to pay dividends.
- Equity-Based Compensation
The Carlyle Group Inc. Amended and Restated 2012 Equity Incentive Plan (the “Equity Incentive Plan,” initially
adopted in May 2012 and as most recently amended and restated on June 3, 2026) is a source of equity-based
awards permitting the Company to grant to Carlyle employees, directors and consultants non-qualified options,
share appreciation rights, common shares, restricted stock units and other awards based on the Company’s shares
of common stock. A total of 77,800,000 shares of common stock are authorized for the grant of awards under the
Equity Incentive Plan, of which a total of 37,498,491 shares of the Company’s common stock remain available for
grant as of September 30, 2026.
A summary of the status of the Company’s unvested equity-based awards as of September 30, 2026 and a
summary of changes for thenine months ended September 30, 2026, are presented below:
| Unvested Shares | Performance-Vesting Restricted Stock Units | Weighted-AverageGrant DateFair Value | RestrictedStockUnits | Weighted-AverageGrant DateFair Value | UnvestedCommonShares | Weighted-AverageGrant DateFair Value |
|---|---|---|---|---|---|---|
| Balance, December 31, 2025 | 14,214,568 | $28.63 | 11,339,034 | $47.36 | 397,838 | $46.04 |
| Granted (1) | 102,885 | $48.87 | 6,910,194 | $57.16 | 126,507 | $61.32 |
| Vested (2) | 5,189,824 | $26.17 | 5,872,229 | $42.27 | 220,517 | $39.62 |
| Forfeited | — | $— | 260,866 | $50.69 | — | $— |
| Balance, September 30, 2026 | 9,127,629 | $30.25 | 12,116,133 | $55.34 | 303,828 | $54.44 |
(1)Includes shares reserved for issuance upon settlement of dividend-equivalent rights carried by certain restricted stock units
concurrently with the settlement of the restricted stock units for shares.
(2)Includes 4,406,553 shares that were retired in connection with the net share settlement of equity-based awards. The
Company paid$229.3 million of taxes related to the net share settlement of equity-based awards during thenine months
ended September 30, 2026, which is included within financing activities in the condensed consolidated statements of cash
flows.
The Company recorded equity-based compensation expense, net of forfeitures, for restricted stock units of
$100.8 million and$90.7 million for thethree months ended September 30, 2026 and 2025, respectively, with
$12.6 million and$15.9 million of corresponding deferred tax benefits, respectively. The Company recorded equity-
based compensation expense, net of forfeitures, for restricted stock units of$336.6 million and$287.1 million for the
nine months ended September 30, 2026 and 2025, respectively, with$45.7 million and$52.6 million of
corresponding deferred tax benefits, respectively. As of September 30, 2026, the total unrecognized equity-based
compensation expense related to unvested restricted stock units was$562.3 million, which is expected to be
recognized over a weighted-average term of 2.2 years.
- Segment Reporting
Carlyle conducts its operations through three reportable segments:
Global Private Equity – The Global Private Equity segment advises buyout, growth, real estate, and
infrastructure & natural resources funds. The segment also includes the NGP Carry Funds advised by NGP.
Global Credit – The Global Credit segment advises funds and vehicles that pursue investment strategies
including insurance solutions, liquid credit, opportunistic credit, direct lending, asset-backed finance, aviation
finance, infrastructure credit, cross-platform credit products, and global capital markets.
Carlyle AlpInvest – The Carlyle AlpInvest segment advises global private equity programs that pursue
secondary purchases and financing of existing portfolios, managed co-investment programs, and primary
fund investments.
The Company’s reportable business segments are differentiated by their various investment focuses and
strategies. Overhead costs are generally allocated based on cash-based compensation and benefits expense for
each segment. The Company’s earnings from its investment in NGP are presented in the respective operating
captions within the Global Private Equity segment.
Distributable Earnings. Distributable Earnings, or “DE,” is a key performance benchmark used in the
Company’s industry and is evaluated regularly by the chief operating decision maker (“CODM”), which is our Chief
Executive Officer, in making resource deployment and compensation decisions and in assessing performance of the
Company’sthree reportable segments. The CODM also uses DE in budgeting, forecasting, and the overall
management of the Company’s segments. The CODM believes that reporting DE is helpful to understanding the
Company’s business and that investors should review the same supplemental financial measure that the CODM
uses to analyze the Company’s segment performance. DE is intended to show the amount of net realized earnings
without the effects of the consolidation of the Consolidated Funds. DE is derived from the Company’s segment
reported results and is used to assess performance.
Distributable Earnings differs from income (loss) before provision for income taxes computed in accordance
with U.S. GAAP in that it includes certain tax expenses associated with certain foreign performance revenues
(composed of performance allocations and incentive fees), and does not include unrealized performance allocations
and related compensation expense, unrealized principal investment income, equity-based compensation expense,
net income (loss) attributable to non-Carlyle interests in consolidated entities, or charges (credits) related to Carlyle
corporate actions and non-recurring items that affect period-to-period comparability and are not reflective of the
Company’s operational performance. Charges (credits) related to Carlyle corporate actions and non-recurring items
include: charges associated with the Conversion, charges (credits) associated with acquisitions, dispositions or
strategic investments, changes in the tax receivable agreement liability, amortization and any impairment charges
associated with acquired intangible assets, transaction costs associated with acquisitions and dispositions, charges
associated with earn-outs and contingent consideration including gains and losses associated with the estimated
fair value of contingent considerations issued in conjunction with acquisitions or strategic investments, impairment
charges associated with lease right-of-use assets, gains and losses from the retirement of debt, charges associated
with contract terminations and employee severance, and non-recurring items that affect period-to-period
comparability and are not reflective of the Company’s operating performance. Management believes the inclusion or
exclusion of these items provides investors with a meaningful indication of the Company’s core operating
performance.
Fee Related Earnings. Fee Related Earnings, or “FRE,” is a component of DE and is used to assess the ability
of the business to cover base compensation and operating expenses from total fee revenues. FRE adjusts DE to
exclude net realized performance revenues, realized principal investment income, and net interest (interest income
less interest expense). Fee Related Earnings includes fee related performance revenues and related compensation
expense. Fee related performance revenues represent the realized portion of performance revenues that are
measured and received on a recurring basis, are not dependent on realization events, and which have no risk of
giveback.
Asset information by segment is not disclosed because this information is not used by the CODM to make
resource deployment decisions or evaluate the performance of the Company’s segments.
The following tables present the financial data for the Company’sthree reportable segments for thethree and
nine months ended September 30, 2026:
| Three Months Ended September 30, 2026 | ||||
|---|---|---|---|---|
| GlobalPrivateEquity | GlobalCredit | Carlyle AlpInvest | Total | |
| (Dollars in millions) | ||||
| Segment Revenues | ||||
| Fund level fee revenues | ||||
| Fund management fees | $272.6 | $161.2 | $113.1 | $546.9 |
| Portfolio advisory and transaction fees, net and other | 5.5 | 27.1 | — | 32.6 |
| Fee related performance revenues | 4.7 | 34.6 | 10.4 | 49.7 |
| Total fund level fee revenues | 282.8 | 222.9 | 123.5 | 629.2 |
| Realized performance revenues | 273.0 | 4.4 | 8.6 | 286.0 |
| Realized principal investment income | 21.0 | 41.3 | 1.8 | 64.1 |
| Interest income | 5.6 | 7.5 | 2.1 | 15.2 |
| Total revenues | 582.4 | 276.1 | 136.0 | 994.5 |
| Segment Expenses | ||||
| Compensation and benefits | ||||
| Cash-based compensation and benefits | 83.0 | 80.0 | 32.1 | 195.1 |
| Realized performance revenues related compensation | 175.0 | 2.8 | 8.4 | 186.2 |
| Total compensation and benefits | 258.0 | 82.8 | 40.5 | 381.3 |
| General, administrative, and other indirect expenses(1) | 59.5 | 44.3 | 20.5 | 124.3 |
| Depreciation and amortization expense | 9.0 | 5.4 | 2.8 | 17.2 |
| Interest expense | 18.7 | 15.5 | 5.0 | 39.2 |
| Total expenses | 345.2 | 148.0 | 68.8 | 562.0 |
| (=) Distributable Earnings | $237.2 | $128.1 | $67.2 | $432.5 |
| (-) Realized net performance revenues | 98.0 | 1.6 | 0.2 | 99.8 |
| (-) Realized principal investment income | 21.0 | 41.3 | 1.8 | 64.1 |
| (+) Net interest | 13.1 | 8.0 | 2.9 | 24.0 |
| (=) Fee Related Earnings | $131.3 | $93.2 | $68.1 | $292.6 |
| Nine Months Ended September 30, 2026 | ||||
|---|---|---|---|---|
| GlobalPrivateEquity | GlobalCredit | Carlyle AlpInvest | Total | |
| (Dollars in millions) | ||||
| Segment Revenues | ||||
| Fund level fee revenues | ||||
| Fund management fees | $840.3 | $457.1 | $354.1 | $1,651.5 |
| Portfolio advisory and transaction fees, net and other | 30.2 | 166.9 | 0.1 | 197.2 |
| Fee related performance revenues | 9.8 | 120.3 | 53.7 | 183.8 |
| Total fund level fee revenues | 880.3 | 744.3 | 407.9 | 2,032.5 |
| Realized performance revenues | 554.2 | 69.3 | 39.1 | 662.6 |
| Realized principal investment income | 38.4 | 57.2 | 19.3 | 114.9 |
| Interest income | 17.9 | 22.5 | 7.2 | 47.6 |
| Total revenues | 1,490.8 | 893.3 | 473.5 | 2,857.6 |
| Segment Expenses | ||||
| Compensation and benefits | ||||
| Cash-based compensation and benefits | 282.6 | 285.2 | 112.1 | 679.9 |
| Realized performance revenues related compensation | 353.8 | 43.0 | 30.9 | 427.7 |
| Total compensation and benefits | 636.4 | 328.2 | 143.0 | 1,107.6 |
| General, administrative, and other indirect expenses(1) | 167.9 | 120.3 | 65.8 | 354.0 |
| Depreciation and amortization expense | 25.3 | 15.1 | 7.9 | 48.3 |
| Interest expense | 55.6 | 45.4 | 14.9 | 115.9 |
| Total expenses | 885.2 | 509.0 | 231.6 | 1,625.8 |
| (=) Distributable Earnings | $605.6 | $384.3 | $241.9 | $1,231.8 |
| (-) Realized net performance revenues | 200.4 | 26.3 | 8.2 | 234.9 |
| (-) Realized principal investment income | 38.4 | 57.2 | 19.3 | 114.9 |
| (+) Net interest | 37.7 | 22.9 | 7.7 | 68.3 |
| (=) Fee Related Earnings | $404.5 | $323.7 | $222.1 | $950.3 |
(1)General, administrative, and other indirect expenses primarily comprised professional fees, rent and other office expenses, IT
expenses, travel and entertainment expenses, and fundraising costs.
The following tables present the financial data for the Company’sthree reportable segments for thethree and
nine months ended September 30, 2025:
| Three Months Ended September 30, 2025 | ||||
|---|---|---|---|---|
| GlobalPrivateEquity | GlobalCredit | Carlyle AlpInvest | Total | |
| (Dollars in millions) | ||||
| Segment Revenues | ||||
| Fund level fee revenues | ||||
| Fund management fees | $295.0 | $146.5 | $132.4 | $573.9 |
| Portfolio advisory and transaction fees, net and other | 6.5 | 25.6 | 0.2 | 32.3 |
| Fee related performance revenues | — | 28.6 | 18.9 | 47.5 |
| Total fund level fee revenues | 301.5 | 200.7 | 151.5 | 653.7 |
| Realized performance revenues | 38.0 | 8.2 | 15.5 | 61.7 |
| Realized principal investment income (loss) | (0.4) | 42.8 | 7.1 | 49.5 |
| Interest income | 7.4 | 8.1 | 2.1 | 17.6 |
| Total revenues | 346.5 | 259.8 | 176.2 | 782.5 |
| Segment Expenses | ||||
| Compensation and benefits | ||||
| Cash-based compensation and benefits | 97.4 | 83.8 | 39.3 | 220.5 |
| Realized performance revenues related compensation | 24.2 | 4.7 | 13.7 | 42.6 |
| Total compensation and benefits | 121.6 | 88.5 | 53.0 | 263.1 |
| General, administrative, and other indirect expenses(1) | 56.2 | 28.5 | 22.6 | 107.3 |
| Depreciation and amortization expense | 7.6 | 4.3 | 2.1 | 14.0 |
| Interest expense | 14.3 | 12.1 | 3.3 | 29.7 |
| Total expenses | 199.7 | 133.4 | 81.0 | 414.1 |
| (=) Distributable Earnings | $146.8 | $126.4 | $95.2 | $368.4 |
| (-) Realized net performance revenues | 13.8 | 3.5 | 1.8 | 19.1 |
| (-) Realized principal investment income (loss) | (0.4) | 42.8 | 7.1 | 49.5 |
| (+) Net interest | 6.9 | 4.0 | 1.2 | 12.1 |
| (=) Fee Related Earnings | $140.3 | $84.1 | $87.5 | $311.9 |
| Nine Months Ended September 30, 2025 | ||||
|---|---|---|---|---|
| GlobalPrivateEquity | GlobalCredit | Carlyle AlpInvest | Total | |
| (Dollars in millions) | ||||
| Segment Revenues | ||||
| Fund level fee revenues | ||||
| Fund management fees | $880.4 | $456.1 | $352.5 | $1,689.0 |
| Portfolio advisory and transaction fees, net and other | 27.9 | 130.0 | 0.2 | 158.1 |
| Fee related performance revenues | — | 86.0 | 39.7 | 125.7 |
| Total fund level fee revenues | 908.3 | 672.1 | 392.4 | 1,972.8 |
| Realized performance revenues | 599.8 | 26.6 | 50.2 | 676.6 |
| Realized principal investment income | 27.1 | 60.3 | 25.6 | 113.0 |
| Interest income | 18.9 | 22.1 | 6.3 | 47.3 |
| Total revenues | 1,554.1 | 781.1 | 474.5 | 2,809.7 |
| Segment Expenses | ||||
| Compensation and benefits | ||||
| Cash-based compensation and benefits | 306.5 | 261.0 | 110.8 | 678.3 |
| Realized performance revenues related compensation | 385.5 | 15.7 | 41.2 | 442.4 |
| Total compensation and benefits | 692.0 | 276.7 | 152.0 | 1,120.7 |
| General, administrative, and other indirect expenses(1) | 155.2 | 99.7 | 54.3 | 309.2 |
| Depreciation and amortization expense | 21.5 | 12.0 | 6.0 | 39.5 |
| Interest expense | 41.1 | 34.9 | 9.5 | 85.5 |
| Total expenses | 909.8 | 423.3 | 221.8 | 1,554.9 |
| (=) Distributable Earnings | $644.3 | $357.8 | $252.7 | $1,254.8 |
| (-) Realized net performance revenues | 214.3 | 10.9 | 9.0 | 234.2 |
| (-) Realized principal investment income | 27.1 | 60.3 | 25.6 | 113.0 |
| (+) Net interest | 22.2 | 12.8 | 3.2 | 38.2 |
| (=) Fee Related Earnings | $425.1 | $299.4 | $221.3 | $945.8 |
(1)General, administrative, and other indirect expenses primarily comprised professional fees, rent and other office expenses, IT
expenses, travel and entertainment expenses, and fundraising costs.
The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes
for thethree months ended September 30, 2026 and 2025.
| Three Months Ended September 30, 2026 | ||||
|---|---|---|---|---|
| Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | |
| (Dollars in millions) | ||||
| Revenues | $994.5 | $175.0 | $(835.4)(a) | $334.1 |
| Expenses | $562.0 | $198.5 | $(372.2)(b) | $388.3 |
| Other income (loss) | $— | $(22.7) | $—(c) | $(22.7) |
| Distributable Earnings | $432.5 | $(46.2) | $(463.2)(d) | $(76.9) |
| Three Months Ended September 30, 2025 | ||||
|---|---|---|---|---|
| Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | |
| (Dollars in millions) | ||||
| Revenues | $782.5 | $163.4 | $(613.2)(a) | $332.7 |
| Expenses | $414.1 | $195.8 | $(239.8)(b) | $370.1 |
| Other income (loss) | $— | $123.2 | $—(c) | $123.2 |
| Distributable Earnings | $368.4 | $90.8 | $(373.4)(d) | $85.8 |
The following tables reconcile the Total Segments to the Company’s Income (Loss) Before Provision for Taxes
for thenine months ended September 30, 2026 and 2025.
| Nine Months Ended September 30, 2026 | ||||
|---|---|---|---|---|
| Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | |
| (Dollars in millions) | ||||
| Revenues | $2,857.6 | $547.2 | $(1,693.2)(a) | $1,711.6 |
| Expenses | $1,625.8 | $570.5 | $(563.5)(b) | $1,632.8 |
| Other income (loss) | $— | $(60.9) | $—(c) | $(60.9) |
| Distributable Earnings | $1,231.8 | $(84.2) | $(1,129.7)(d) | $17.9 |
| Nine Months Ended September 30, 2025 | ||||
|---|---|---|---|---|
| Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | |
| (Dollars in millions) | ||||
| Revenues | $2,809.7 | $459.8 | $(390.8)(a) | $2,878.7 |
| Expenses | $1,554.9 | $505.1 | $297.4(b) | $2,357.4 |
| Other income (loss) | $— | $176.1 | $—(c) | $176.1 |
| Distributable Earnings | $1,254.8 | $130.8 | $(688.2)(d) | $697.4 |
(a)The Revenues adjustment principally represents unrealized performance revenues, unrealized principal
investment income (loss) (including Fortitude), revenues earned from the Consolidated Funds which were
eliminated in consolidation to arrive at the Company’s total revenues, adjustments for amounts attributable to
non-controlling interests in consolidated entities, adjustments related to expenses associated with the
investments in NGP Management and its affiliates that are included in operating captions or are excluded
from the segment results, and adjustments to reflect the reimbursement of certain costs incurred on behalf of
Carlyle funds on a net basis, as detailed below:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Unrealized performance and fee related performance revenues | $(815.1) | $(632.0) | $(1,685.1) | $(498.3) |
| Unrealized principal investment income (loss) | (13.6) | (7.4) | (132.7) | 35.1 |
| Adjustments related to expenses associated with investments in NGP Management and its affiliates | (11.2) | (12.3) | (34.0) | (120.8) |
| Non-controlling interests and other adjustments to present certain costs on a net basis | (10.2) | 56.5 | 91.3 | 254.3 |
| Elimination of revenues of Consolidated Funds | 14.7 | (18.0) | 67.3 | (61.1) |
| $(835.4) | $(613.2) | $(1,693.2) | $(390.8) | |
The following table reconciles the total segments fund level fee revenue to the most directly comparable U.S.
GAAP measure, the Company’s consolidated fund management fees, for thethree and nine months ended
September 30, 2026 and 2025.
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Total Reportable Segments - Fund level fee revenues | $629.2 | $653.7 | $2,032.5 | $1,972.8 |
| Adjustments(1) | (73.8) | (70.4) | (236.1) | (183.0) |
| Carlyle Consolidated - Fund management fees | $555.4 | $583.3 | $1,796.4 | $1,789.8 |
(1)Adjustments represent the reclassification of NGP management fees from principal investment income,
the reclassification of fee related performance revenues from certain products, management fees
earned from Consolidated Funds which were eliminated in consolidation to arrive at the Company’s
fund management fees, and the reclassification of certain amounts included in portfolio advisory fees,
net and other in the segment results that are included in Interest and other income in the U.S. GAAP
results.
The following table reconciles the total segments transaction and portfolio advisory fees, net and other to the
most directly comparable U.S. GAAP measure, the Company’s consolidated transaction and portfolio
advisory fees, net for thethree and nine months ended September 30, 2026 and 2025.
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Total Reportable Segments - Portfolio advisory and transaction fees, net and other | $32.6 | $32.3 | $197.2 | $158.1 |
| Adjustments(1) | (4.9) | (11.2) | (11.7) | (14.5) |
| Carlyle Consolidated - Portfolio advisory and transaction fees, net | $27.7 | $21.1 | $185.5 | $143.6 |
(1)Adjustments represent the reclassification of other income from Interest and other income in the U.S.
GAAP results and certain underwriting fees from Principal investment income.
(b)The Expenses adjustment represents the elimination of intercompany expenses of the Consolidated Funds
payable to the Company, the inclusion of equity-based compensation, certain tax expenses associated with
realized performance revenues related compensation, unrealized performance revenues related
compensation, adjustments related to expenses associated with the investment in NGP Management that
are included in operating captions, adjustments to reflect the reimbursement of certain costs incurred on
behalf of Carlyle funds on a net basis, changes in the tax receivable agreement liability, and charges and
credits associated with Carlyle corporate actions and non-recurring items, as detailed below:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Unrealized performance and fee related performance revenue compensation expense | $(533.6) | $(387.4) | $(1,078.0) | $(288.0) |
| Equity-based compensation | 102.3 | 88.2 | 341.1 | 289.3 |
| Acquisition or disposition-related charges and amortization of intangibles and impairment | 41.8 | 46.2 | 133.1 | 216.7 |
| Tax (expense) benefit associated with certain foreign performance revenues related compensation | 0.1 | (0.4) | 0.5 | (0.5) |
| Non-controlling interests and other adjustments to present certain costs on a net basis | 22.2 | 23.9 | 79.7 | 98.1 |
| Other adjustments | 1.0 | 8.2 | 8.3 | 25.3 |
| Elimination of expenses of Consolidated Funds | (6.0) | (18.5) | (48.2) | (43.5) |
| $(372.2) | $(239.8) | $(563.5) | $297.4 | |
(c)Represents Other Income (Loss) of Consolidated Funds which are excluded from the Company’s segment
reporting.
(d)The following table is a reconciliation of Income (Loss) Before Provision for Income Taxes to Distributable
Earnings and to Fee Related Earnings:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Income (loss) before provision for income taxes | $(76.9) | $85.8 | $17.9 | $697.4 |
| Adjustments: | ||||
| Net unrealized performance and fee related performance revenues | 281.5 | 244.6 | 607.1 | 210.3 |
| Unrealized principal investment (income) loss | 13.6 | 7.4 | 132.7 | (35.1) |
| Equity-based compensation(1) | 102.3 | 88.2 | 341.1 | 289.3 |
| Acquisition or disposition-related charges, including amortization of intangibles and impairment | 41.8 | 46.2 | 133.1 | 216.7 |
| Tax (expense) benefit associated with certain foreign performance revenues | 0.1 | (0.4) | 0.5 | (0.5) |
| Net (income) loss attributable to non-controlling interests in consolidated entities | 69.1 | (111.6) | (8.9) | (148.6) |
| Other adjustments(2) | 1.0 | 8.2 | 8.3 | 25.3 |
| Distributable Earnings | $432.5 | $368.4 | $1,231.8 | $1,254.8 |
| (-) Realized performance revenues, net of related compensation(3) | 99.8 | 19.1 | 234.9 | 234.2 |
| (-) Realized principal investment income(3) | 64.1 | 49.5 | 114.9 | 113.0 |
| (+) Net interest | 24.0 | 12.1 | 68.3 | 38.2 |
| Fee Related Earnings | $292.6 | $311.9 | $950.3 | $945.8 |
(1)Equity-based compensation included amounts that are presented in principal investment income (loss) and
general, administrative and other expenses in the Company’s condensed consolidated statements of operations.
(2)Includes charges (credits) related to Carlyle corporate actions and non-recurring items that affect period-to-period
comparability and are not reflective of the Company’s operating performance.
(3)See reconciliation to most directly comparable U.S. GAAP measure below:
| Three Months Ended September 30, 2026 | |||
|---|---|---|---|
| CarlyleConsolidated | Adjustments (4) | TotalReportableSegments | |
| (Dollars in millions) | |||
| Performance revenues | $(626.6) | $912.6 | $286.0 |
| Performance revenues related compensation expense | (334.5) | 520.7 | 186.2 |
| Net performance revenues | $(292.1) | $391.9 | $99.8 |
| Principal investment income (loss) | $119.3 | $(55.2) | $64.1 |
| Nine Months Ended September 30, 2026 | |||
| CarlyleConsolidated | Adjustments (4) | TotalReportableSegments | |
| (Dollars in millions) | |||
| Performance revenues | $(1,263.0) | $1,925.6 | $662.6 |
| Performance revenues related compensation expense | (608.8) | 1,036.5 | 427.7 |
| Net performance revenues | $(654.2) | $889.1 | $234.9 |
| Principal investment income (loss) | $252.9 | $(138.0) | $114.9 |
| Three Months Ended September 30, 2025 | |||
|---|---|---|---|
| CarlyleConsolidated | Adjustments (4) | TotalReportableSegments | |
| (Dollars in millions) | |||
| Performance revenues | $(606.7) | $668.4 | $61.7 |
| Performance revenues related compensation expense | (324.6) | 367.2 | 42.6 |
| Net performance revenues | $(282.1) | $301.2 | $19.1 |
| Principal investment income (loss) | $87.7 | $(38.2) | $49.5 |
| Nine Months Ended September 30, 2025 | |||
| CarlyleConsolidated | Adjustments (4) | TotalReportableSegments | |
| (Dollars in millions) | |||
| Performance revenues | $255.0 | $421.6 | $676.6 |
| Performance revenues related compensation expense | 290.4 | 152.0 | 442.4 |
| Net performance revenues | $(35.4) | $269.6 | $234.2 |
| Principal investment income (loss) | $79.8 | $33.2 | $113.0 |
(4)Adjustments to performance revenues and principal investment income (loss) relate to (i) unrealized performance
allocations net of related compensation expense and unrealized principal investment income, which are excluded
from the segment results, (ii) amounts earned from the Consolidated Funds, which are eliminated in the U.S. GAAP
consolidation but are included in the segment results, (iii) amounts attributable to non-controlling interests in
consolidated entities, which are excluded from the segment results, (iv) the reclassification of NGP performance
revenues, which are included in principal investment income in the U.S. GAAP financial statements, (v) the
reclassification of fee related performance revenues, which are included in fund level fee revenues in the segment
results, and (vi) the reclassification of tax expenses associated with certain foreign performance revenues.
Adjustments to principal investment income (loss) also include the reclassification of earnings for the investments in
NGP Management and its affiliates to the appropriate operating captions for the segment results, and the exclusion
of charges associated with the investment in NGP Management and its affiliates from the segment results.
- Subsequent Events
Subsequent events have been evaluated through the date the condensed consolidated financial statements
were issued. There have been no subsequent events that require recognition or disclosure through the date the
condensed consolidated financial statements were issued, except as disclosed below and elsewhere in these
condensed consolidated financial statements.
In October 2026, the Company’s Board of Directors declared a quarterly dividend of $0.35 per share of
common stock to common shareholders of record at the close of business on November 16, 2026, payable on
November 23, 2026.
- Supplemental Financial Information
The following supplemental financial information illustrates the consolidating effects of the Consolidated Funds
on the Company’s financial position as of September 30, 2026 and December 31, 2025 and results of operations for
thethree and nine months ended September 30, 2026 and 2025. The supplemental statement of cash flows is
presented without effects of the Consolidated Funds.
| As of September 30, 2026 | ||||
|---|---|---|---|---|
| ConsolidatedOperatingEntities | ConsolidatedFunds | Eliminations | Consolidated | |
| (Dollars in millions) | ||||
| Assets | ||||
| Cash and cash equivalents | $1,583.5 | $— | $— | $1,583.5 |
| Cash and cash equivalents held at Consolidated Funds | — | 1,021.5 | — | 1,021.5 |
| Investments, including accrued performance allocations of $5,801.3 | 10,565.6 | — | (1,164.9) | 9,400.7 |
| Investments of Consolidated Funds | — | 13,709.2 | — | 13,709.2 |
| Due from affiliates and other receivables, net | 1,317.0 | — | (301.1) | 1,015.9 |
| Due from affiliates and other receivables of Consolidated Funds, net | — | 324.5 | — | 324.5 |
| Fixed assets, net | 256.6 | — | — | 256.6 |
| Lease right-of-use assets, net | 310.6 | — | — | 310.6 |
| Deposits and other | 73.7 | 5.1 | — | 78.8 |
| Intangible assets, net | 408.0 | — | — | 408.0 |
| Deferred tax assets | 70.1 | — | — | 70.1 |
| Total assets | $14,585.1 | $15,060.3 | $(1,466.0) | $28,179.4 |
| Liabilities and equity | ||||
| Debt obligations | $3,016.7 | $— | $— | $3,016.7 |
| Loans payable of Consolidated Funds | — | 12,000.0 | (284.0) | 11,716.0 |
| Accounts payable, accrued expenses and other liabilities | 411.3 | — | — | 411.3 |
| Accrued compensation and benefits | 4,569.9 | — | — | 4,569.9 |
| Due to affiliates | 210.7 | 10.3 | (3.1) | 217.9 |
| Deferred revenue | 358.6 | — | — | 358.6 |
| Deferred tax liabilities | 17.9 | — | — | 17.9 |
| Other liabilities of Consolidated Funds | — | 718.1 | (0.7) | 717.4 |
| Lease liabilities | 436.9 | — | — | 436.9 |
| Accrued giveback obligations | 120.2 | — | — | 120.2 |
| Total liabilities | 9,142.2 | 12,728.4 | (287.8) | 21,582.8 |
| Common stock | 3.6 | — | — | 3.6 |
| Additional paid-in capital | 4,666.4 | 1,208.0 | (1,208.0) | 4,666.4 |
| Retained earnings | 525.7 | — | — | 525.7 |
| Accumulated other comprehensive loss | (248.0) | 24.0 | 29.8 | (194.2) |
| Non-controlling interests in consolidated entities | 495.2 | 1,099.9 | — | 1,595.1 |
| Total equity | 5,442.9 | 2,331.9 | (1,178.2) | 6,596.6 |
| Total liabilities and equity | $14,585.1 | $15,060.3 | $(1,466.0) | $28,179.4 |
| As of December 31, 2025 | ||||
|---|---|---|---|---|
| ConsolidatedOperatingEntities | ConsolidatedFunds | Eliminations | Consolidated | |
| (Dollars in millions) | ||||
| Assets | ||||
| Cash and cash equivalents | $1,970.2 | $— | $— | $1,970.2 |
| Cash and cash equivalents held at Consolidated Funds | — | 1,235.1 | — | 1,235.1 |
| Investments, including accrued performance allocations of $7,620.3 | 12,219.6 | — | (1,066.9) | 11,152.7 |
| Investments of Consolidated Funds | — | 12,519.8 | — | 12,519.8 |
| Due from affiliates and other receivables, net | 1,135.0 | — | (300.2) | 834.8 |
| Due from affiliates and other receivables of Consolidated Funds, net | — | 206.4 | — | 206.4 |
| Fixed assets, net | 224.9 | — | — | 224.9 |
| Lease right-of-use assets, net | 331.9 | — | — | 331.9 |
| Deposits and other | 98.2 | 2.7 | — | 100.9 |
| Intangible assets, net | 507.1 | — | — | 507.1 |
| Deferred tax assets | 32.2 | — | — | 32.2 |
| Total assets | $16,519.1 | $13,964.0 | $(1,367.1) | $29,116.0 |
| Liabilities and equity | ||||
| Debt obligations | $2,997.0 | $— | $— | $2,997.0 |
| Loans payable of Consolidated Funds | — | 10,712.4 | (286.4) | 10,426.0 |
| Accounts payable, accrued expenses and other liabilities | 543.7 | — | — | 543.7 |
| Accrued compensation and benefits | 5,849.4 | — | — | 5,849.4 |
| Due to affiliates | 197.8 | 6.1 | — | 203.9 |
| Deferred revenue | 129.2 | — | — | 129.2 |
| Deferred tax liabilities | 106.3 | — | — | 106.3 |
| Other liabilities of Consolidated Funds | — | 1,260.7 | (0.3) | 1,260.4 |
| Lease liabilities | 470.2 | — | — | 470.2 |
| Accrued giveback obligations | 72.8 | — | — | 72.8 |
| Total liabilities | 10,366.4 | 11,979.2 | (286.7) | 22,058.9 |
| Common stock | 3.6 | — | — | 3.6 |
| Additional paid-in capital | 4,285.8 | 1,099.2 | (1,099.2) | 4,285.8 |
| Retained earnings | 1,642.3 | — | — | 1,642.3 |
| Accumulated other comprehensive loss | (213.1) | 24.1 | 18.8 | (170.2) |
| Non-controlling interests in consolidated entities | 434.1 | 861.5 | — | 1,295.6 |
| Total equity | 6,152.7 | 1,984.8 | (1,080.4) | 7,057.1 |
| Total liabilities and equity | $16,519.1 | $13,964.0 | $(1,367.1) | $29,116.0 |
| Three Months Ended September 30, 2026 | ||||
|---|---|---|---|---|
| ConsolidatedOperatingEntities | ConsolidatedFunds | Eliminations | Consolidated | |
| (Dollars in millions) | ||||
| Revenues | ||||
| Fund management fees | $566.7 | $— | $(11.3) | $555.4 |
| Incentive fees | 51.6 | — | — | 51.6 |
| Investment income (loss) | ||||
| Performance allocations | (627.6) | — | 1.0 | (626.6) |
| Principal investment income | 88.1 | — | 31.2 | 119.3 |
| Total investment loss | (539.5) | — | 32.2 | (507.3) |
| Interest and other income | 65.6 | — | (6.2) | 59.4 |
| Interest and other income of Consolidated Funds | — | 175.0 | — | 175.0 |
| Total revenues | 144.4 | 175.0 | 14.7 | 334.1 |
| Expenses | ||||
| Compensation and benefits | ||||
| Cash-based compensation and benefits | 196.5 | — | — | 196.5 |
| Equity-based compensation | 100.8 | — | — | 100.8 |
| Performance allocations and incentive fee related compensation | (334.5) | — | — | (334.5) |
| Total compensation and benefits | (37.2) | — | — | (37.2) |
| General, administrative and other expenses | 193.9 | — | (0.1) | 193.8 |
| Interest | 39.1 | — | — | 39.1 |
| Interest and other expenses of Consolidated Funds | — | 198.5 | (5.9) | 192.6 |
| Total expenses | 195.8 | 198.5 | (6.0) | 388.3 |
| Other loss | ||||
| Net investment loss of Consolidated Funds | — | (22.7) | — | (22.7) |
| Loss before provision for income taxes | (51.4) | (46.2) | 20.7 | (76.9) |
| Benefit for income taxes | (0.1) | — | — | (0.1) |
| Net loss | (51.3) | (46.2) | 20.7 | (76.8) |
| Net loss attributable to non-controlling interests in consolidated entities | (43.6) | — | (25.5) | (69.1) |
| Net loss attributable to The Carlyle Group Inc. | $(7.7) | $(46.2) | $46.2 | $(7.7) |
| Nine Months Ended September 30, 2026 | ||||
|---|---|---|---|---|
| ConsolidatedOperatingEntities | ConsolidatedFunds | Eliminations | Consolidated | |
| (Dollars in millions) | ||||
| Revenues | ||||
| Fund management fees | $1,831.1 | $— | $(34.7) | $1,796.4 |
| Incentive fees | 202.2 | — | — | 202.2 |
| Investment income (loss) | ||||
| Performance allocations | (1,260.5) | — | (2.5) | (1,263.0) |
| Principal investment income | 126.8 | — | 126.1 | 252.9 |
| Total investment loss | (1,133.7) | — | 123.6 | (1,010.1) |
| Interest and other income | 197.5 | — | (21.6) | 175.9 |
| Interest and other income of Consolidated Funds | — | 547.2 | — | 547.2 |
| Total revenues | 1,097.1 | 547.2 | 67.3 | 1,711.6 |
| Expenses | ||||
| Compensation and benefits | ||||
| Cash-based compensation and benefits | 685.5 | — | — | 685.5 |
| Equity-based compensation | 336.6 | — | — | 336.6 |
| Performance allocations and incentive fee related compensation | (608.8) | — | — | (608.8) |
| Total compensation and benefits | 413.3 | — | — | 413.3 |
| General, administrative and other expenses | 581.3 | — | — | 581.3 |
| Interest | 115.9 | — | — | 115.9 |
| Interest and other expenses of Consolidated Funds | — | 570.5 | (48.2) | 522.3 |
| Total expenses | 1,110.5 | 570.5 | (48.2) | 1,632.8 |
| Other loss | ||||
| Net investment loss of Consolidated Funds | — | (60.9) | — | (60.9) |
| Income (loss) before provision for income taxes | (13.4) | (84.2) | 115.5 | 17.9 |
| Provision for income taxes | 11.8 | — | — | 11.8 |
| Net income (loss) | (25.2) | (84.2) | 115.5 | 6.1 |
| Net income (loss) attributable to non-controlling interests in consolidated entities | (22.4) | — | 31.3 | 8.9 |
| Net loss attributable to The Carlyle Group Inc. | $(2.8) | $(84.2) | $84.2 | $(2.8) |
| Three Months Ended September 30, 2025 | ||||
|---|---|---|---|---|
| ConsolidatedOperatingEntities | ConsolidatedFunds | Eliminations | Consolidated | |
| (Dollars in millions) | ||||
| Revenues | ||||
| Fund management fees | $600.0 | $— | $(16.7) | $583.3 |
| Incentive fees | 53.8 | — | (2.4) | 51.4 |
| Investment income | ||||
| Performance allocations | (598.2) | — | (8.5) | (606.7) |
| Principal investment income | 71.4 | — | 16.3 | 87.7 |
| Total investment income (loss) | (526.8) | — | 7.8 | (519.0) |
| Interest and other income | 60.3 | — | (6.7) | 53.6 |
| Interest and other income of Consolidated Funds | — | 163.4 | — | 163.4 |
| Total revenues | 187.3 | 163.4 | (18.0) | 332.7 |
| Expenses | ||||
| Compensation and benefits | ||||
| Cash-based compensation and benefits | 216.2 | — | — | 216.2 |
| Equity-based compensation | 90.7 | — | — | 90.7 |
| Performance allocations and incentive fee related compensation | (324.6) | — | — | (324.6) |
| Total compensation and benefits | (17.7) | — | — | (17.7) |
| General, administrative and other expenses | 180.7 | — | — | 180.7 |
| Interest | 29.8 | — | — | 29.8 |
| Interest and other expenses of Consolidated Funds | — | 195.8 | (18.5) | 177.3 |
| Total expenses | 192.8 | 195.8 | (18.5) | 370.1 |
| Other income (loss) | ||||
| Net investment income of Consolidated Funds | — | 123.2 | — | 123.2 |
| Income (loss) before provision (benefit) for income taxes | (5.5) | 90.8 | 0.5 | 85.8 |
| Benefit for income taxes | (26.7) | — | — | (26.7) |
| Net income | 21.2 | 90.8 | 0.5 | 112.5 |
| Net income attributable to non-controlling interests in consolidated entities | 20.3 | — | 91.3 | 111.6 |
| Net income attributable to The Carlyle Group Inc. | $0.9 | $90.8 | $(90.8) | $0.9 |
| Nine Months Ended September 30, 2025 | ||||
|---|---|---|---|---|
| ConsolidatedOperatingEntities | ConsolidatedFunds | Eliminations | Consolidated | |
| (Dollars in millions) | ||||
| Revenues | ||||
| Fund management fees | $1,822.4 | $— | $(32.6) | $1,789.8 |
| Incentive fees | 138.0 | — | (2.9) | 135.1 |
| Investment income | ||||
| Performance allocations | 265.2 | — | (10.2) | 255.0 |
| Principal investment income (loss) | 77.1 | — | 2.7 | 79.8 |
| Total investment income | 342.3 | — | (7.5) | 334.8 |
| Interest and other income | 177.3 | — | (18.1) | 159.2 |
| Interest and other income of Consolidated Funds | — | 459.8 | — | 459.8 |
| Total revenues | 2,480.0 | 459.8 | (61.1) | 2,878.7 |
| Expenses | ||||
| Compensation and benefits | ||||
| Cash-based compensation and benefits | 673.0 | — | — | 673.0 |
| Equity-based compensation | 287.1 | — | — | 287.1 |
| Performance allocations and incentive fee related compensation | 290.4 | — | — | 290.4 |
| Total compensation and benefits | 1,250.5 | — | — | 1,250.5 |
| General, administrative and other expenses | 559.8 | — | — | 559.8 |
| Interest | 85.6 | — | — | 85.6 |
| Interest and other expenses of Consolidated Funds | — | 505.1 | (43.5) | 461.6 |
| Other non-operating income | (0.1) | — | — | (0.1) |
| Total expenses | 1,895.8 | 505.1 | (43.5) | 2,357.4 |
| Other income | ||||
| Net investment income of Consolidated Funds | — | 176.1 | — | 176.1 |
| Income before provision for income taxes | 584.2 | 130.8 | (17.6) | 697.4 |
| Provision for income taxes | 98.2 | — | — | 98.2 |
| Net income | 486.0 | 130.8 | (17.6) | 599.2 |
| Net income attributable to non-controlling interests in consolidated entities | 35.4 | — | 113.2 | 148.6 |
| Net income attributable to The Carlyle Group Inc. | $450.6 | $130.8 | $(130.8) | $450.6 |
| Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| (Dollars in millions) | ||
| Cash flows from operating activities | ||
| Net income (loss) | $(25.2) | $486.0 |
| Adjustments to reconcile net income to net cash flows from operating activities: | ||
| Depreciation and amortization | 153.8 | 143.1 |
| Equity-based compensation | 336.6 | 287.1 |
| Non-cash performance allocations and incentive fees | 680.0 | 2.7 |
| Non-cash principal investment (income) loss | (92.8) | (32.5) |
| Other non-cash amounts | (2.5) | 35.9 |
| Purchases of investments | (995.2) | (872.6) |
| Proceeds from the sale of investments | 977.2 | 807.6 |
| Payments of contingent consideration | (14.8) | (2.7) |
| Change in deferred taxes, net | (109.0) | (67.5) |
| Change in due from affiliates and other receivables | 1.0 | (8.1) |
| Change in deposits and other | 19.8 | (25.4) |
| Change in accounts payable, accrued expenses and other liabilities | (116.9) | 37.8 |
| Change in accrued compensation and benefits | (187.4) | (61.4) |
| Change in due to affiliates | 20.6 | 25.1 |
| Change in lease right-of-use assets and lease liabilities | (11.7) | (9.7) |
| Change in deferred revenue | 229.8 | 226.7 |
| Net cash provided by operating activities | 863.3 | 972.1 |
| Cash flows from investing activities | ||
| Purchases of fixed assets, net | (87.5) | (57.4) |
| Net cash used in investing activities | (87.5) | (57.4) |
| Cash flows from financing activities | ||
| Issuance of 5.05% senior notes due 2035, net of financing costs | — | 792.9 |
| Payments on CLO borrowings | (67.9) | (52.0) |
| Proceeds from CLO borrowings, net of financing costs | 97.9 | 64.8 |
| Dividends to common shareholders | (376.6) | (379.2) |
| Contributions from non-controlling interest holders | 269.9 | 116.9 |
| Distributions to non-controlling interest holders | (151.7) | (83.9) |
| Common shares repurchased and net share settlement of equity-based awards | (719.3) | (482.8) |
| Change in due to/from affiliates financing activities | (208.8) | 29.4 |
| Net cash provided by (used in) financing activities | (1,156.5) | 6.1 |
| Effect of foreign exchange rate changes | (8.6) | 39.1 |
| Increase (decrease) in cash, cash equivalents and restricted cash | (389.3) | 959.9 |
| Cash, cash equivalents and restricted cash, beginning of period | 1,973.6 | 1,266.5 |
| Cash, cash equivalents and restricted cash, end of period | $1,584.3 | $2,226.4 |
| Reconciliation of cash, cash equivalents and restricted cash, end of period: | ||
| Cash and cash equivalents | $1,583.5 | $2,221.7 |
| Restricted cash | 0.8 | 4.7 |
| Total cash, cash equivalents and restricted cash, end of period | $1,584.3 | $2,226.4 |
| Cash and cash equivalents held at Consolidated Funds | $1,021.5 | $1,037.3 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.